<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures ...  - RSC Advances (RSC Publishing) DOI:10.1039/C9RA08690K</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/ra/c9ra08690k"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":53,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Waldemar Tejchman"/><meta name="DC.Creator" content="Bartosz Orwat"/><meta name="DC.Creator" content="Izabela Korona-Głowniak"/><meta name="DC.Creator" content="Anna Barbasz"/><meta name="DC.Creator" content="Ireneusz Kownacki"/><meta name="DC.Creator" content="Gniewomir Latacz"/><meta name="DC.Creator" content="Jadwiga Handzlik"/><meta name="DC.Creator" content="Ewa Żesławska"/><meta name="DC.Creator" content="Anna Malm"/><meta name="DC.title" content="Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures and antibacterial activity  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2019/11/29"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C9RA08690K"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures and antibacterial activity  "/><meta name="citation_author" content="Waldemar Tejchman"/><meta name="citation_author" content="Bartosz Orwat"/><meta name="citation_author" content="Izabela Korona-Głowniak"/><meta name="citation_author" content="Anna Barbasz"/><meta name="citation_author" content="Ireneusz Kownacki"/><meta name="citation_author" content="Gniewomir Latacz"/><meta name="citation_author" content="Jadwiga Handzlik"/><meta name="citation_author" content="Ewa Żesławska"/><meta name="citation_author" content="Anna Malm"/><meta name="citation_online_date" content="2019/11/29"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="9"/><meta name="citation_issue" content="67"/><meta name="citation_firstpage" content="39367"/><meta name="citation_lastpage" content="39380"/><meta name="citation_doi" content="10.1039/C9RA08690K"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/ra/c9ra08690k"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/ra/c9ra08690k"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/ra/c9ra08690k"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/ra/c9ra08690k">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c9ra07289f)" href="/en/content/articlehtml/2019/ra/c9ra07289f" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c9ra07397c)" href="/en/content/articlehtml/2019/ra/c9ra07397c" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C9RA08690K">10.1039/C9RA08690K</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2019, <strong>9</strong>, 39367-39380</div><h1 id="sect219"><span class="title_heading">Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures and antibacterial activity<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
<span class="bold">Waldemar Tejchman</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Waldemar Tejchman (orcid.org/0000-0001-8336-4288) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-8336-4288"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Bartosz Orwat</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Bartosz Orwat (orcid.org/0000-0003-1210-0095) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-1210-0095"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">bc</span></sup>, 
<span class="bold">Izabela Korona-Głowniak</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Izabela Korona-Głowniak (orcid.org/0000-0003-1634-0387) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-1634-0387"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">d</span></sup>, 
<span class="bold">Anna Barbasz</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Anna Barbasz (orcid.org/0000-0001-5210-2349) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-5210-2349"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Ireneusz Kownacki</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Ireneusz Kownacki (orcid.org/0000-0002-5445-760X) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-5445-760X"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">bc</span></sup>, 
<span class="bold">Gniewomir Latacz</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Gniewomir Latacz (orcid.org/0000-0001-9247-2598) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-9247-2598"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">e</span></sup>, 
<span class="bold">Jadwiga Handzlik</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Jadwiga Handzlik (orcid.org/0000-0002-3674-3581) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-3674-3581"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">e</span></sup>, 
<span class="bold">Ewa Żesławska</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Ewa Żesławska (orcid.org/0000-0003-1946-9370) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-1946-9370"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup><span class="bold"> and </span>
<span class="bold">Anna Malm</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Anna Malm (orcid.org/0000-0003-1503-7634) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-1503-7634"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">d</span></sup>
<br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Department of Chemistry, Institute of Biology, Pedagogical University of Cracow, Podchorążych 2, 30-084 Kraków, Poland</span>
<br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland. E-mail: <a href="mailto:b.orwat@amu.edu.pl">b.orwat@amu.edu.pl</a></span>
<br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Centre for Advanced Technology, Uniwersytetu Poznańskiego 10, 61-614 Poznań, Poland</span>
<br/><a id="affd"><sup><span class="sup_ref italic">d</span></sup></a><span class="italic">Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland</span>
<br/><a id="affe"><sup><span class="sup_ref italic">e</span></sup></a><span class="italic">Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</span>
</p><div id="art-admin"><span class="italic bold">Received 
23rd October 2019
</span><span class="bold italic">, Accepted 15th November 2019</span></div><p class="bold italic">First published on 29th November 2019</p><hr/><div class="abstract"><h2>Abstract</h2><p>Here we report studies on the synthesis of 12 new heterocyclic derivatives that differ in three structural motifs and the simultaneous evaluation of the impact of these three variables on the biological properties. The examined compounds are based on rhodanine and 2-thiohydantoin cores equipped with hydrogen or carboxymethyl substituents at the N-3 position and linked to a triphenylamine moiety through 1,4-phenylene, 1,4-naphthalenylene and 1,9-anthracenylene spacers at the C-5 position of the heterocycles. All the compounds were synthesized very quickly, selectively and in high yields according to the developed microwave-assisted Knoevenagel condensation protocol, and they were characterized thoroughly with NMR, FT-IR and ESI-HRMS techniques. The derivatives were tested for their activity against selected strains of Gram-positive and Gram-negative bacteria and yeast. Two compounds showed good activity against Gram-positive bacteria, and all of them showed low cytotoxicity against three cell lines of the human immune system. Based on membrane permeability assays it was demonstrated that the active compounds do not penetrate the cell membrane, and thus they must act on the bacterial cell surface. Finally, we proved that the evaluated structure modifications had a synergistic effect and the simultaneous presence of a 1,4-phenylene spacer and carboxymethyl group at N-3 caused the highest boost in antimicrobial activity.</p></div><hr/>
<h2 id="sect322"><span class="a_heading">Introduction</span></h2>
<span>Throughout evolution, many pathogenic microorganisms have gained resistance to antibiotics, and this constitutes a threat to public health.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> This ongoing process is a serious challenge for modern medicinal chemistry, but it also stimulates development in the field. For this reason, many research groups seek new substances that can efficiently act against pathogenic microorganisms without posing a risk to patients. Among the pathogens, many dangerous ones belong to the kingdom of bacteria. These organisms can be classified into two groups based on the Gram staining result that indicates differences in their structure, physiology and drug resistance. Gram-negative bacteria have an outer membrane of their cell walls that makes it difficult for antibiotics to penetrate into the cell.<a title="Select to navigate to reference" href="#cit2"><sup><span class="sup_ref">2–4</span></sup></a> In addition, in the periplasmic space located between the outer and the inner membrane, there are enzymes that deactivate antibiotics.<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a> Gram-positive bacteria do not have an outer membrane, but the structure of their peptidoglycan is more complicated than in Gram-negative bacteria.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> The lack of an outer membrane facilitates the penetration of antibiotics into the cells and increases the number of molecular targets on the cell wall surface that can be attacked by substances with antibacterial activity.</span>
<p class="otherpara">There are well-known and particularly dangerous lethal diseases such as tuberculosis, leprosy and gas gangrene which are caused by Gram-positive bacteria; cholera, brucellosis, plague, syphilis and salmonellosis that are caused by Gram-negative bacteria. In the search for a cure against them, many scientists have synthesized various heterocyclic compounds and studied their bactericidal properties.<a title="Select to navigate to reference" href="#cit7"><sup><span class="sup_ref">7,8</span></sup></a> Among others, derivatives of five-membered heterocyclic systems based on the core of 1,3-thiazolidine or imidazolidine have been studied due to their broad biological activity.<a title="Select to navigate to reference" href="#cit9"><sup><span class="sup_ref">9,10</span></sup></a> Of particular interest are their derivatives containing exocyclic sulfur and oxygen atoms, such as rhodanine (2-sulfanylidene-1,3-thiazolidin-4-one)<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> or 2-thiohydantoin (2-sulfanylidene-1,3-diazolidin-4-one).<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> The presence of these double-bonded atoms with other functional groups results in particularly high density of binding sites for polar interactions and hydrogen bonds, which are responsible for their interesting biological properties.<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> A spectrum of their biological activity includes antifungal,<a title="Select to navigate to reference" href="#cit14"><sup><span class="sup_ref">14,15</span></sup></a> anticancer,<a title="Select to navigate to reference" href="#cit16"><sup><span class="sup_ref">16–18</span></sup></a> antidiabetic,<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> anti-inflammatory,<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> antiviral,<a title="Select to navigate to reference" href="#cit22"><sup><span class="sup_ref">22,23</span></sup></a> anticonvulsant<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24–26</span></sup></a> and enzyme-inhibiting properties.<a title="Select to navigate to reference" href="#cit27"><sup><span class="sup_ref">27,28</span></sup></a> Another noteworthy feature of such cyclic systems is their strong polar and electron-withdrawing character, making them popular anchoring and electron-accepting groups in construction of merocyanine dyes for organic dye-sensitized solar cells (DSSC).<a title="Select to navigate to reference" href="#cit29"><sup><span class="sup_ref">29–31</span></sup></a> Additionally, the popularity of these heterocycles as building blocks is supported by the feasibility of their multi-functionalization in various positions (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-s1.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">General structure of rhodanine (left) and 2-thiohydantoin (right). R groups mark positions of their potential functionalization.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">In our previous research we proved that antibacterial activity of the examined rhodanine-3-carboxylic acid series were strengthened with the increase in hydrophobic character of the substituent in position 5.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> Moreover, the lowest minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were observed for derivatives equipped with a triphenylamine moiety. This result indicated that a coexistence of aromatic rings and multi-interacting heterocycles within the same molecule might be a key requirement for enabling its activity. This conclusion prompted us to explore the topic for similar reports in the literature. In the search, we encountered some works describing activity of familiar derivatives. Tomašić <span class="italic">et al.</span> also reported that the increase of hydrophobicity of a benzylidene substituent in the rhodanine C-5 position led to an increase in antimicrobial activity.<a title="Select to navigate to references" href="#cit33"><sup><span class="sup_ref">33</span></sup></a> Among all examined compounds, 5-(2,3,4-trifluorobenzylidene)-rhodanine exhibited the highest activity, inhibiting <span class="italic">Staphylococcus aureus</span> and MRSA growth at concentrations of 0.5 and 32 mg L<small><sup>−1</sup></small>, respectively. A series of substituted rhodanines bearing benzylidene-derived fragments of various steric hindrance in position 5 showed also activity towards MRSA.<a title="Select to navigate to references" href="#cit34"><sup><span class="sup_ref">34</span></sup></a> Derivatives of hydantoin, an oxygen analogue of 2-thiohydantoin bearing a bulky 4-methyl-2-phenyl-furo[(3,2-<span class="italic">d</span>)pyrazole(3,2-<span class="italic">d</span>)imidazole] moiety in C-5, also showed antimicrobial activity against <span class="italic">Escherichia coli</span> and <span class="italic">Staphylococcus aureus</span>.<a title="Select to navigate to references" href="#cit35"><sup><span class="sup_ref">35</span></sup></a> Furthermore, it was proved that the steric and electronic properties of the C-5 substituent affect bactericidal activity in the series of various chlorinated 5-arylidene rhodanines.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> It is noteworthy that compounds containing lipophilic, condensed aromatic moieties like naphthalene might exhibit better antibacterial activity than those containing unfused aromatics in the C-5 position (<span class="italic">e.g.</span> 1,1′-biphenyl or <span class="italic">p</span>-methoxyphenylazosalicylidene moiety).<a title="Select to navigate to reference" href="#cit37"><sup><span class="sup_ref">37,38</span></sup></a> The incorporation of such moieties might also affect other biological properties. Sing <span class="italic">et al.</span> proved that the incorporation of larger and more hydrophobic substituents in the C-5 position of rhodanine 3-acetic acid can increase HCV NS3 protease inhibition selectivity up to 25 times compared to a derivative bearing biphenyl moiety.<a title="Select to navigate to references" href="#cit39"><sup><span class="sup_ref">39</span></sup></a> It is therefore prerequisite that the size and lipophilicity of C-5 substituents can modulate biological activity of 5-substituted rhodanine and its analogues. We mentioned before that the C-5 substituent effect might not be the only parameter modulating activity. As Trotsko <span class="italic">et al.</span> showed, antibacterial activity of 2-thiohydantoin derivatives was slightly higher than the corresponding rhodanine derivatives.<a title="Select to navigate to references" href="#cit40"><sup><span class="sup_ref">40</span></sup></a> Consequently, we believe that the heterocycle is another binding point for interaction with enzymes or receptors, and that its core structure might alter the final compound's activity. Finally, the substituent in the N-3 position is also very important. As Sim <span class="italic">et al.</span> observed, rhodanine derivatives containing alkyl or aryl groups in this position do not show antibacterial activity. The highest antibacterial activity is exhibited in compounds equipped with hydrogen or carboxylic acid in the N-3 position.<a title="Select to navigate to references" href="#cit34"><sup><span class="sup_ref">34</span></sup></a> To sum up, we are convinced that in order to design a substance with high antibacterial activity, the total effect of three variable points, namely the C-5 substituent, the heterocycle core structure and the N-3 substituent, should be taken into account. These variables should be examined together within the same molecule since they might synergistically influence binding to active centers, but we did not find such an approach for rhodanine and 2-thiohydantoin derivatives in the literature.</p>
<p class="otherpara">Due to the lack of thorough evaluation of aromatic linker size effect evaluation on the biological properties of rhodanine and 2-thiohydantoin derivatives, we decided to fill in this gap. Therefore, we designed and synthesized a series of merocyanine dyes consisting of the mentioned heterocycles with a triphenylamine moiety bonded through a hydrocarbon aromatic linker in position C-5. For this purpose, 1,4-phenylene, 1,4-naphthalenylene and 1,10-anthracenylene were selected as the simplest homologue linkers. Guided by the literature, we have undertaken to find a cumulative effect of linker size, heterocycle core component and ancillary N-3 substituent (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) on biological properties. Our goal was to determine how the variation of the three interacting points influence antibacterial activity and cytotoxicity of the tested compounds, and to shed some light on their mechanisms of activity.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-s2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-s2.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-s2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Illustration of the concept and the differences between the compounds investigated in this work.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h2 id="sect372"><span class="a_heading">Results and discussion</span></h2>
<h3 id="sect374"><span class="b_heading">Synthesis</span></h3>
<span>The proposed synthetic protocol for the target molecules was based on Knoevenagel condensation of 4′-(diphenylamino)-[1,1′-biphenyl]-4-carbaldehyde (<strong>1a</strong>), 4-(4-(diphenylamino)phenyl)-1-naphthalenecarbaldehyde (<strong>1b</strong>) and 10-(4-(diphenylamino)phenyl)anthracene-9-carbaldehyde (<strong>1c</strong>) with rhodanines (<strong>2a</strong>, <strong>2b</strong>) and thiohydantoins (<strong>3a</strong>, <strong>3b</strong>). The former aldehydes were prepared in the course of a Suzuki–Miyaura cross-coupling reaction, the most commonly used of the palladium-mediated reactions in the synthesis of active pharmaceutical ingredients (APIs).<a title="Select to navigate to reference" href="#cit41"><sup><span class="sup_ref">41,42</span></sup></a> Therefore, in the first step of synthetic work, 4-(diphenylamino)phenylboronic acid, 4-bromo-1-naphthalenecarbaldehyde and 10-bromo-9-anthracenecarbaldehyde were prepared with slightly modified literature methods.<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43–45</span></sup></a> Then we started the synthesis of the intermediate aldehydes <strong>1a–c</strong>. At the beginning we decided to examine the reliability of the reported synthetic protocol for <strong>1a</strong>.<a title="Select to navigate to references" href="#cit46"><sup><span class="sup_ref">46</span></sup></a> To our surprise, we obtained the product in 70% yield, which differs significantly from the reported value of 98%. Moreover, this method proved to be completely ineffective in the coupling of the two other bromoarenecarbaldehydes. We suppose that this was due to their low solubility in the 2-propanol/water reaction medium used. Even after raising the reaction temperature to 100 °C, there were formed sticky clumps which probably hampered further progress of the reaction. In the face of this obstacle, we decided to use a different solvent system to facilitate the solubility of the reactants. Fortunately, changing the reaction medium to a mixture of toluene, ethanol and 2 M aqueous K<small><sub>2</sub></small>CO<small><sub>3</sub></small> solution enabled us to efficiently perform all cross-coupling reactions with very good yields (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>). As a result, aldehydes <strong>1a–c</strong> were isolated by the means of flash chromatography purification in the form of yellow or orange solids.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch3"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-s3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-s3.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-s3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 3 </b> <span id="sch3"><span class="graphic_title">Synthesis of the aldehyde intermediates through Suzuki–Miyaura cross-coupling.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">After successful preparation of intermediates <strong>1a–c</strong>, we focused on the Knoevenagel condensation of the aldehydes with selected heterocycles. Such transformation is a well-known method for C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>C bond formation; however, the results of this reaction are not always satisfactory. Additionally, in the most reported protocols, prolonged heating of the reaction mixture in reflux conditions followed by recrystallization of the product were required, resulting in medium yields.<a title="Select to navigate to reference" href="#cit47"><sup><span class="sup_ref">47–49</span></sup></a> During our thorough literature review, we encountered the promising concept of microwave-accelerated Knoevenagel condensation.<a title="Select to navigate to references" href="#cit50"><sup><span class="sup_ref">50</span></sup></a> Because this unconventional heat source has recently been proved to increase the efficiency of various catalytic and stoichiometric reactions in our group,<a title="Select to navigate to references" href="#cit51"><sup><span class="sup_ref">51</span></sup></a> we decided to examine its effectiveness in our current work. Preliminary tests in which anthracene-9-carbaldehyde and rhodanine were involved as a model reagent system confirmed the superior efficiency of microwave irradiation compared to a classical oil bath. Thus, we decided to apply the former as a heat source in our synthetic protocol. The first reported reactions were conducted with rhodanines <strong>2a</strong> and <strong>2b</strong> according to <a title="Select to navigate to scheme" href="#imgsch4">Scheme 4</a>.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch4"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-s4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-s4.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-s4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 4 </b> <span id="sch4"><span class="graphic_title">Knoevenagel condensation of rhodanines (<strong>2a</strong>, <strong>2b</strong>) with aldehydes (<strong>1a</strong>, <strong>1b</strong>, <strong>1c</strong>).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">During the synthesis of the desired compounds, we observed that the reactions started almost immediately at elevated temperature, evidenced by the change of reaction mixture color mostly from yellow to intense red or orange. At this point, we noticed that the progress of the condensation correlated with the size of the aromatic linker. The reason for this might be the increase in steric hindrance in the surrounding of the formyl group from <strong>1a</strong> to <strong>1c</strong>, resulting in a decrease in yield from <strong>4a</strong> to <strong>4c</strong> and <strong>5a</strong> to <strong>5c</strong>. Because of this, reaction time was extended to 6 and 7 minutes for aldehydes bearing 1,4-naphthalenylene and 9,10-anthracenylene linkers in their structures, respectively. Nevertheless, a slight trend in decreasing yield was still observed.</p>
<p class="otherpara">The same reaction conditions were applied in the condensation processes involving 2-thiohydantoins <strong>3a</strong> and <strong>3b</strong>. It is worth emphasizing that in the condensations involving <strong>3a</strong>, the substrate was equipped with an acetyl group in position N-1 due to superior feasibility of its synthesis compared to related unprotected 2-thiohydantoin.<a title="Select to navigate to references" href="#cit52"><sup><span class="sup_ref">52</span></sup></a> However, the acetyl group was cleaved <span class="italic">in situ</span> in an acidic environment during the Knoevenagel reaction, yielding N-1 deprotected derivatives of 2-thiohydantoin (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5</a>).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch5"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-s5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-s5.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-s5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 5 </b> <span id="sch5"><span class="graphic_title">Knoevenagel condensation of 2-thiohydantoins (<strong>3a</strong>, <strong>3b</strong>) with aldehydes (<strong>1a</strong>, <strong>1b</strong>, <strong>1c</strong>).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara"><a title="Select to navigate to table" href="#tab1">Table 1</a> summarizes the yields of all isolated target compounds. It is evident that 2-thiohydantoin derivatives are characterized by lower yields than rhodanines. This difference is most likely due to the replacement of the less electronegative sulfur atom in position 1 for an –NH– moiety. Such a trend is more pronounced for the compounds bearing a 1,4-phenylene and 9,10-anthracenylene linker in their structures than those comprising a 1,4-naphthalenylene moiety. It should be emphasized that all the compounds were obtained with good to excellent yields, and most were isolated by simple filtration and rinsing. In the case of compounds <strong>6c</strong> and <strong>7c</strong>, conversion of the starting aldehyde was insufficiently low, causing contamination of the crude product with an observable amount of unreacted <strong>1c</strong> that could not be separated by simple rinsing of the obtained solid. This was probably caused by π–π stacking of condensed aromatic linker that is more favored with the increase in aromatic moiety size. It may also explain the lack of contamination problems in the case of products bearing smaller aromatic linkers in their structures. Nonetheless, this problem was solved by simple recrystallization. In this way we have finally developed a successful protocol for the synthesis of the desired compounds, providing ourselves materials for further studies of their biological activity. Additionally, aldehydes <strong>1a–c</strong> and heterocyclic derivatives <strong>4a–7c</strong> were fully characterized by nuclear magnetic resonance spectroscopy (NMR), high resolution mass spectrometry (HRMS) and Fourier-transform infrared spectroscopy (FTIR), providing high quality identification of the new compounds. All spectra were included in the ESI.<a title="Select to navigate to footnote" href="#fn1">†</a></p>

<div class="table_caption"><b>Table 1</b> <span id="tab1">Comparison of the yields of the target compounds</span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/></colgroup>




<thead align="left">
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black">Molecule's fragment</th>
<th align="left" valign="bottom" class="border_black"><p align="center"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u1.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u1.gif"/></a></p></th>
<th align="left" valign="bottom" class="border_black"><p align="center"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u2.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u2.gif"/></a></p></th>
<th align="left" valign="bottom" class="border_black"><p align="center"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u3.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u3.gif"/></a></p></th>
</tr>
</thead>
<tbody align="left">
<tr align="left">
<td valign="top"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u4.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u4.gif"/></a></td>
<td valign="top">96% (<strong>4a</strong>)</td>
<td valign="top">94% (<strong>4b</strong>)</td>
<td valign="top">90% (<strong>4c</strong>)</td>
</tr>
<tr align="left">
<td valign="top"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u5.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u5.gif"/></a></td>
<td valign="top">94% (<strong>5a</strong>)</td>
<td valign="top">90% (<strong>5b</strong>)</td>
<td valign="top">89% (<strong>5c</strong>)</td>
</tr>
<tr align="left">
<td valign="top"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u6.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u6.gif"/></a></td>
<td valign="top">72% (<strong>6a</strong>)</td>
<td valign="top">86% (<strong>6b</strong>)</td>
<td valign="top">74% (<strong>6c</strong>)</td>
</tr>
<tr align="left">
<td valign="top"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-u7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-u7.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-u7.gif"/></a></td>
<td valign="top">84% (<strong>7a</strong>)</td>
<td valign="top">85% (<strong>7b</strong>)</td>
<td valign="top">74% (<strong>7c</strong>)</td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>

<h3 id="sect493"><span class="b_heading">Antibacterial activity</span></h3>
<span>In order to examine biological activity of the synthesized compounds, MIC and MBC values were determined to quantify their influence on selected strains of Gram-positive and Gram-negative bacteria, as well as yeast. <span class="italic">Escherichia coli</span> ATCC25922, <span class="italic">Salmonella typhimurium</span> ATCC14028, <span class="italic">Klebsiella pneumoniae</span> ATCC13883, <span class="italic">Pseudomonas aeruginosa</span> ATCC9027 and <span class="italic">Proteus mirabilis</span> ATCC12453 were selected as model strain of Gram-negative bacteria. <span class="italic">Staphylococcus aureus</span> ATCC25923, <span class="italic">Staphylococcus aureus</span> ATCC6538, <span class="italic">Staphylococcus aureus</span> ATCC43300, <span class="italic">Staphylococcus epidermidis</span> ATCC12228, <span class="italic">Micrococcus luteus</span> ATCC10240, <span class="italic">Bacillus subtilis</span> ATCC6633, <span class="italic">Bacillus cereus</span> ATCC10876, <span class="italic">Streptococcus pyogenes</span> ATCC19615, <span class="italic">Streptococcus pneumoniae</span> ATCC49619 and <span class="italic">Streptococcus mutans</span> ATCC25175 were selected as Gram-positive bacteria. Finally, the yeast <span class="italic">Candida albicans</span> ATCC10231, <span class="italic">Candida albicans</span> ATCC2091, <span class="italic">Candida parapsilosis</span> ATCC22019, <span class="italic">Candida glabrata</span> ATCC 90030 and <span class="italic">Candida crusei</span> ATCC14243 were selected. Ciprofloxacin and vancomycin were used as reference positive controls (Table 3S<a title="Select to navigate to footnote" href="#fn1">†</a>). None of the tested compounds demonstrated activity against Gram-negative bacteria and yeast (MIC &gt; 1000 mg L<small><sup>−1</sup></small>, data not shown). Tables 1S and 2S,<a title="Select to navigate to footnote" href="#fn1">†</a> containing a complete set of measured data against Gram-positive bacteria, are included in the ESI.<a title="Select to navigate to footnote" href="#fn1">†</a></span>
<p class="otherpara">Comparison of the data compiled in Tables 1S and 2S<a title="Select to navigate to footnote" href="#fn1">†</a> prompted us to conclude that rhodanine derivatives are more biologically active than 2-thiohydantoin derivatives in general. Among all tested strains, <span class="italic">M. luteus</span> ATCC 10240 appeared to be the most sensitive to the examined compounds, while <span class="italic">S. mutans</span> ATCC 25175 was the most resistant (sensitive only to <strong>7a</strong> however, in the high concentration of 62.5 mg L<small><sup>−1</sup></small>). As one can see, compounds <strong>5a</strong> and <strong>7a</strong> are characterized by significantly outstanding values of the determined parameters. Activity of these compounds is discussed in detail below.</p>
<p class="otherpara"><a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a> presents the activity of compound <strong>5a</strong>. MIC values for <strong>5a</strong> range from 0.98 mg L<small><sup>−1</sup></small> for <span class="italic">S. epidermidis</span> ATCC12228 and <span class="italic">M. luteus</span> ATCC10240, to a level of 1000 mg L<small><sup>−1</sup></small> against <span class="italic">M. mutans</span> ATCC25175 (not presented in the chart to maintain clarity). MBC values were also determined in order to establish whether the examined substance has bacteriostatic or bactericidal effect. For most strains, MBC was significantly higher than MIC, allowing us to assume less bactericidal activity. For this quantification the MBC/MIC ratio was calculated, since if it is ≤4, the examined compound is recognized as bactericidal.<a title="Select to navigate to references" href="#cit53"><sup><span class="sup_ref">53</span></sup></a> <strong>5a</strong> showed the satisfactory MBC/MIC ratios against <span class="italic">B. subtilis</span> ATCC 6633, <span class="italic">S. aureus</span> ATCC 6538, <span class="italic">S. aureus</span> ATCC 43300 and <span class="italic">B. cereus</span> ATCC 10876, while for the other strains the determined ratios were in the range of 8–32.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-f1.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Activity of <strong>5a</strong> against selected strains of Gram-positive bacteria.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara"><a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a> presents activity of <strong>7a</strong> with exclusion of data for <span class="italic">S. mutans</span> ATCC 25175 (MBC &gt; 1000 mg L<small><sup>−1</sup></small>). Measured MIC values range from 1.95 mg L<small><sup>−1</sup></small> against <span class="italic">S. aureus</span> ATCC6538, <span class="italic">S. aureus</span> ATCC43300, <span class="italic">S. epidermidis</span> ATCC12228 and <span class="italic">M. luteus</span> ATCC10240 to 125 mg L<small><sup>−1</sup></small> for <span class="italic">B. cereus</span> ATCC10876. The corresponding MBC values range from 3.9 mg L<small><sup>−1</sup></small> to 250 mg L<small><sup>−1</sup></small>, which indicates a less varied response of <strong>7a</strong> compared to <strong>5a</strong>. For the nine presented strains, MIC/MBC ratios were not satisfactory only in the case of <span class="italic">M. luteus</span> ATCC 10240, which had a value of 16.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-f2.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Activity of <strong>7a</strong> against selected strains of Gram-positive bacteria.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Comparison of the MBC/MIC ratios, determined for the two most active compounds, leads to the conclusion that <strong>7a</strong> has better bactericidal characteristics than <strong>5a</strong>. In the case of <strong>7a</strong>, values of MBC/MIC ratio usually range from 1 to 4, while for <strong>5a</strong> the typical range is from 1 to 32. However, compound <strong>5a</strong> is generally characterized by lower MIC values, proving its higher inhibitory activity. It should be emphasized that the mentioned differences are caused only by the replacement of the sulfur atom with the –NH– moiety in position 1 of the heterocycle. Another noted relationship is the influence of a carboxymethyl substituent on MIC and MBC values. If we compare <strong>4a</strong> <span class="italic">vs.</span> <strong>5a</strong> and <strong>6a</strong> <span class="italic">vs.</span> <strong>7a</strong>, it is seen that the presence of the mentioned substituent in position 3 of the heterocycle has an enormous boosting effect on biological activity. This very significant observation might serve as confirmation of the role of the carboxylic group in the activity of the examined compounds. Our findings might be supported by the results of Talele <span class="italic">et al.</span>, who investigated the antiviral activity of 5-(3-phenoxybenzylidene) rhodanine-3-acetic acid derivatives. Their target was HC5 hepatitis C virus (HCV) polymerase.<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> They observed that a carboxylic group in the N-3 position of the rhodanine ring formed a hydrogen bond with the guanidine group of arginine. The exocyclic oxygen atom in the C-4 position of the rhodanine ring also took part in the formation of hydrogen bonds. Based on the former, we suppose that rhodanine and 2-thiohydantoin derivatives without a carboxyl group in the N-3 position have fewer binding centers and thus cannot produce sufficiently strong hydrogen bonds with amino acid side chains present in the enzymes/receptors. In consequence, their antibacterial activity is much lower than the derivatives that can form hydrogen bonds.</p>
<p class="otherpara">A previously examined 5-(4′-<span class="italic">N</span>,<span class="italic">N</span>-diphenylaminobenzylidene)-rhodanine-3-acetic acid demonstrated biological activity (MIC 1.95–500 mg L<small><sup>−1</sup></small>, MBC/MIC 2–4) similar to the activity of <strong>5a</strong>.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> The chemical structures of both compounds differed by the presence of an additional 1,4-phenylene linker between the triphenylamine and rhodanine moieties. Introducing the phenylene linker to the structure of 5-(4′-<span class="italic">N</span>,<span class="italic">N</span>-diphenylaminobenzylidene)-rhodanine-3-acetic acid resulted in a slight increase in the biological activity, especially against <span class="italic">S. pyogenes</span> ATCC19615 and <span class="italic">S. pneumoniae</span> ATCC49619. However, bactericidal properties of the obtained derivative became lower at the same time. Further increase in the aromatic linker size (1,4-naphthalenylene or 9,10-anthracenylene) resulted in a decrease or even total block of biological activity. Unfortunately, we could not perform a similar comparison for <strong>7a</strong> since analogous 5-(4′-<span class="italic">N</span>,<span class="italic">N</span>-diphenylaminobenzylidene)-2-thiohydantoin-3-acetic acid has not been reported in literature.</p>
<p class="otherpara">Based on these results, we concluded that the presence of both a carboxymethyl group in the N-3 position and a triphenylamine moiety connected through a 1,4-phenylene linker in the C-5 position are crucial for the desirable biological activity of rhodanine and 2-thiohydantoin derivatives. Moreover, the activity can be modulated to some extent with introduction of an aromatic linker.</p>

<h3 id="sect594"><span class="b_heading">Cytotoxicity toward human immune cell lines</span></h3>
<span>After evaluation of the antibacterial properties of <strong>4a–7c</strong>, we focused our research on their influence on three human immune system cell lines. The immune cells present in the body are responsible for protection against infections caused by microorganisms or xenobiotics; thus, potential antimicrobial compounds should be characterized by low cytotoxicity towards immune cells in order to support its efficacy. The group of three chosen cell lines consisted of U-937 monocytic cells, a non-adherent cells differentiable to monocytes and macrophages;<a title="Select to navigate to reference" href="#cit55"><sup><span class="sup_ref">55,56</span></sup></a> T-cell lymphoma HUT-78 line, exhibiting the features of a mature T-cell line with inducer/helper phenotype<a title="Select to navigate to references" href="#cit57"><sup><span class="sup_ref">57</span></sup></a> and the B lymphoblastoid COLO-720L cell line, growing in the form of characteristic clumps.<a title="Select to navigate to references" href="#cit58"><sup><span class="sup_ref">58</span></sup></a> The results are presented below in the graphical form of charts, while the raw data are grouped in Table 4S.<a title="Select to navigate to footnote" href="#fn1">†</a></span>
<p class="otherpara"><a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a> (top) presents the LD<small><sub>50</sub></small> of rhodanine derivatives against the examined cell lines. As can be clearly seen, the cytotoxicity for series <strong>4a–c</strong> is inversely proportional to the increase of the aromatic linker size, for all cell lines. In contrast, introduction of an acidic moiety in position N-3 results in higher cytotoxicity in general. In the series <strong>5a–c</strong>, LD<small><sub>50</sub></small> is less diversified with only one anomalously high value of <strong>5a</strong> for the HUT-78 line. However, the origin of this deviation remains unknown. In the case of rhodanine derivatives, the highest cytotoxicity was observed for compounds bearing a 1,4-phenylene linker, for all cell lines (except for the mentioned example of <strong>5a</strong> against the HUT-78 cell line).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2019/RA/c9ra08690k/c9ra08690k-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9ra08690k-f3.tif" src="/image/article/2019/RA/c9ra08690k/c9ra08690k-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">LD<small><sub>50</sub></small> of rhodanine (<strong>4a–c</strong>, top left), rhodanine-3-acetic acid (<strong>5a–c</strong>, top right), 2-thiohydantoin (<strong>6a–c</strong>, bottom left), and 2-thiohydantoin-3-acetic acid (<strong>7a–c</strong>, bottom right) derivatives, determined for three human immune system cell lines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">A similar set of data for the derivatives of 2-thiohydantoin is presented in the <a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a> (bottom). The demonstrated compounds show more varied cytotoxicity with respect to the rhodanine analogs. Compounds <strong>6a–c</strong> are characterized by the same relative values of LD<small><sub>50</sub></small> against U-937 and COLO-720L lines; however, their activity towards HUT-78 line does not follow these trends. Interestingly, compounds <strong>7a–c</strong> exhibited similar behavior. Moreover, the highest LD<small><sub>50</sub></small> values from all the compounds were recorded for <strong>6c</strong> and <strong>7b</strong> against the HUT-78 line, representing the highest anomalies in the <strong>6a–c</strong> and <strong>7a–c</strong> series. Leaving behind these exceptions, 2-thiohydantoin derivatives <strong>6b</strong>, <strong>6c</strong>, <strong>7b</strong> and <strong>7c</strong> showed almost unchanged cytotoxicity against the three examined cell lines.</p>
<p class="otherpara">The measured LD<small><sub>50</sub></small> for line U-937 was between 17.81 and 34.44 mg L<small><sup>−1</sup></small>; for cell line HUT-78 between 15.93 and 67.63 mg L<small><sup>−1</sup></small>; and for cell line COLO-720L it was between 21.34 and 44.58 mg L<small><sup>−1</sup></small>. As demonstrated, the examined compounds were shown to be the most cytotoxic against U-937 line and the least toxic against HUT-78 line. Moreover, the latter cell line showed significantly variable response to treatment with <strong>4a–7c</strong>, thus proving its sensitivity towards the chemical structure of the examined compounds. However, no regularity was observed. In contrast to that, cytotoxicity towards U-937 and COLO-720L was much less variable. Notwithstanding, we observed very similar trends of activity towards these two cell lines for compounds bearing 1,4-phenylene (compounds <strong>a</strong>) and 9,10-anthracenylene (compounds <strong>c</strong>) linkers. It is also worth noting that among compounds <strong>4–7c</strong>, derivatives containing a carboxymethyl group in the N-3 position always exhibited higher cytotoxicity toward all examined cell lines, compared to derivatives with a hydrogen substituent in the same position.</p>
<p class="otherpara">To sum up this section, we conclude that all examined compounds showed very low cytotoxicity towards the examined U-937, HUT-78 and COLO-720L cell lines. For all the compounds, significantly higher LD<small><sub>50</sub></small> values than MIC values were measured for compounds <strong>5a</strong> and <strong>7a</strong>, thus confirming their selective toxicity against bacteria and non-toxicity towards selected human immune system cells. Based on the results obtained so far, we decided to briefly explore their probable mechanisms of action.</p>

<h3 id="sect644"><span class="b_heading">Membrane permeability</span></h3>
<span>Our attention was drawn to the differences in general activity of <strong>4a–7c</strong> against various microorganisms. The fact that the compounds affected only Gram-positive bacteria, and not Gram-negative bacteria or yeast, allowed us to speculate about the mechanism of interaction. According to the literature, potential antibiotics can interfere with various molecular targets, causing malfunction of pathogens' systems.<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> These interactions can be classified into five main categories: (1) inhibition of specific enzymes (especially gene expression enzymes <span class="italic">e.g.</span>, topoisomerases); (2) inhibition of RNA synthesis; (3) inhibition of protein synthesis; (4) inhibition of cytoplasmic membrane precursor synthesis; and (5) blocking the functions of the cytoplasmic membrane. The first four actions can occur only if the antibiotic is successfully transferred through the cell membrane and into the cytoplasm. In contrast, the last process requires antibiotic molecules to bind to receptors or enzymes present on the cell surface, as penicillin and other β-lactam antibiotics do. In the search for potential targets for rhodanine and 2-thiohydantoin derivatives, we referred to the literature.</span>
<p class="otherpara">In almost all bacteria, the main component of the cell wall is peptidoglycan. This polymer protects the cell from changes in osmotic pressure as well as physical, chemical and mechanical agents. Therefore, disturbance of its synthesis or rendering it dysfunctional might induce the cell's death.<a title="Select to navigate to reference" href="#cit60"><sup><span class="sup_ref">60,61</span></sup></a> Mendgen <span class="italic">et al.</span> examined the inhibitory effect of 5-arylideno rhodanines and 2-thiohydantoins towards MurA, one of the enzymes responsible for peptidoglycan synthesis.<a title="Select to navigate to references" href="#cit62"><sup><span class="sup_ref">62</span></sup></a> They discovered that their activity might be caused by the special electronic properties conferred by the exocyclic double-bonded sulfur atom, empowering molecule-to-enzyme binding. Another important enzyme, MurB reductase, was also examined regarding its interaction with 5-substituted rhodanines. In the reported theoretical studies, it was shown that molecular docking might be particularly preferred in the case of naphthyl-derived rhodanines due to their interaction with the lipophilic area of the enzyme's active site. On the other hand, the disturbance of peptidoglycan synthesis might also occur on the cell's surface as a result of interaction with penicillin-binding proteins (PBPs). These proteins catalyze the final steps of peptidoglycan synthesis (maturing), thus affecting its proper construction.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> Disturbance of such a process was examined for 5-arylalkylidenerhodanines and 5-arylalkylidene-2-iminothiazolidin-4-ones, and it proved to inhibit cell wall growth in Gram-positive bacteria in the case of some tested compounds.<a title="Select to navigate to references" href="#cit64"><sup><span class="sup_ref">64</span></sup></a> As one can see, it is possible that the compounds examined in our work can hamper the peptidoglycan synthetic pathway due to structural similarity.</p>
<p class="otherpara">In order to test whether our compounds inhibit the activity of enzymes operating in the cytoplasm, or rather act only on the cell's surface, we performed a parallel artificial membrane permeability assay (PAMPA) test for several of them. We chose the most active compound <strong>5a</strong> along with <strong>5b</strong> and <strong>5c</strong> in order to verify any possible relationship between linker size and membrane permeability. The results of the studies clearly showed that none of the tested compounds had the ability to penetrate the cell membrane. During PAMPA tests we observed that the examined compounds underwent isomerization process which might be attributed to the sunlight irradiation<a title="Select to navigate to reference" href="#cit65"><sup><span class="sup_ref">65,66</span></sup></a> or the interaction with the membrane. Due to the structural similarities of all studied compounds, we suppose that none of <strong>4a–7c</strong> will be able to reach the interior of the cells. Despite the inability to penetrate the cell wall, compounds <strong>5a</strong> and <strong>7a</strong> showed high antibacterial activity. Based on the PAMPA test results, their Gram-positive antibacterial activity must be due to outer-cell interaction. We suspect that the compounds exhibiting antibacterial activity may bind to the active centers of the enzymes responsible for the cross-linking of the peptidoglycan structure, causing them to inactivate and consequently impair the protective function of the cell wall. This may particularly occur for derivatives containing a carboxymethyl group in the N-3 position, a group capable of forming hydrogen bonds with nucleophilic sites of the enzymes. However, a necessary condition also appears to be the presence of a 1,4-phenylene linker in combination with a triphenylamine moiety, which results in a good fit of the entire C-5 substituent to the hydrophobic pocket of the enzyme. If both conditions are met, the change of –S– to –NH– group in the C-1 position of the heterocycle shows a little effect on MIC reduction and a significant improvement in bactericidal properties by reducing the MIC/MBC ratio. The significantly lower antibacterial activity of the other derivatives, or even its lack, confirms the key role of the abovementioned structural motifs. In addition, significantly lower activity of compounds subjected to a single structure modification in reference to <strong>5a</strong> and <strong>7a</strong> indicates a synergistic effect of the three structural variables. Due to inactivity of <strong>4a–7c</strong> towards Gram-negative bacteria, we believe that these compounds are neutralized within the periplasmic space.</p>


<h2 id="sect667"><span class="a_heading">Conclusions</span></h2>
<span>In summary, we obtained two series of new rhodanine and 2-thiohydantoin derivatives containing a triphenylamine moiety, differing in the heterocyclic core as well as the number of condensed aromatic rings in the linker and the N-3 substituent of the heterocycles. The target compounds were obtained in a two-step process involving Suzuki–Miyaura cross-coupling and highly efficient microwave-assisted Knoevenagel condensation. In the course of further research, we determined antibacterial properties, cytotoxicity against human immune system cells and permeability through cell membranes. The most active turned out to be derivatives containing a 1,4-phenylene moiety, and as the size of the aromatic linker increased, their activity decreased noticeably. In addition, the antibacterial properties of the compounds bearing a 1,4-phenylene linker were significantly enhanced by introducing the carboxymethyl substituent in the N-3 position, proving the synergy of these structural modifications. Among the tested compounds, <strong>5a</strong> and <strong>7a</strong> showed the highest activity, while rhodanine derivative <strong>5a</strong> was characterized by a higher activity in the inhibition of the bacterial growth, whereas 2-thiohydantoin derivative <strong>7a</strong> was more bactericidal. In addition, the cytotoxicity of the examined compounds against three cell lines of the human immune system: U-937, HUT-78 and COLO-720L was found to be very low. PAMPA tests excluded the ability of the compounds to penetrate the cells which suggested that the activity of <strong>4a–7c</strong> is associated only with their interaction with molecular targets located on the surface of the cell membrane. A more detailed explanation of the antimicrobial mechanism of activity of compounds <strong>5a</strong> and <strong>7a</strong> will constitute the next stage of our work.</span>

<h2 id="sect677"><span class="a_heading">Experimental section</span></h2>
<h3 id="sect679"><span class="b_heading">General information</span></h3>
<span>Acetic acid (AA), acetic anhydride, acetonitrile (ACN), aminoethanoic acid, ammonium thiocyanate, carbon disulfide, chloroacetic acid, ethanol, dichloromethane (DCM), <span class="italic">N</span>,<span class="italic">N</span>-dimethylformamide (DMF), methanol, pentane, tetrahydrofuran (THF), toluene, 4-bromo-<span class="italic">N</span>,<span class="italic">N</span>-diphenylaniline, <span class="italic">n</span>-butyllithium (1.6 M solution in hexanes), trimethyl borate, triphenylphosphine, naphthalene, bromine, potassium carbonate, potassium hydroxide, sodium hydroxide and 9-anthracenecarbaldehyde were obtained from Sigma-Aldrich; 2-propanol (IPA), hexanes, ethyl acetate, 4-bromobenzaldehyde and palladium(<span class="small_caps">II</span>) chloride from POCH, while deuterated solvents were purchased from Deutero GmbH and Sigma-Aldrich. Rhodanine,<a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a> rhodanine-3-acetic acid,<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> 1-acetyl-2-thiohydantoin,<a title="Select to navigate to reference" href="#cit50"><sup><span class="sup_ref">50,69</span></sup></a> 2-thiohydantoin-3-acetic acid<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> and dichlorobis (triphenylophosphine)palladium(<span class="small_caps">II</span>)<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a> were prepared following the cited papers. 4-(diphenylamino)phenylboronic acid, 1,4-dibromonaphthalene, 4-bromo-1-naphthalenecarbaldehyde and 10-bromo-9-anthracenecarbaldehyde,<a title="Select to navigate to reference" href="#cit72"><sup><span class="sup_ref">72,73</span></sup></a> were synthesized according to the published procedures with slight modifications.</span>
<p class="otherpara">Lithiation reactions and Suzuki–Miyaura couplings were performed under an inert atmosphere, using standard vacuum-gas manifold (99.999% argon). For these transformations, all reagents and solvents were deoxygenated and moreover, DMF and THF were dehydrated. DMF was dried over calcium hydride, while THF over sodium/benzophenone, and both distilled prior to use. Other reactions were conducted under air atmosphere without special precautions, using reagents and solvents as received from the suppliers. Reactions accelerated with microwave irradiation were conducted in CEM microwave 10 mL vials with CEM Discover, a pressurized microwave reactor.</p>
<p class="otherpara">The reaction progress was monitored by means of a gas chromatograph (Bruker 450-GC) coupled to a mass detector (Bruker MS-320) and thin layer chromatography (TLC). Chemical structures of the obtained compounds were confirmed by nuclear magnetic resonance (NMR) spectroscopy using Bruker Ultrashield 300 MHz and Bruker Ascend 600 MHz spectrometers. CDCl<small><sub>3</sub></small>, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small> and DMSO-d<small><sub>6</sub></small> were used for NMR analysis with residual solvent peak as the internal standard (chloroform <small><sup>1</sup></small>H <span class="italic">δ</span> = 7.26 ppm, <small><sup>13</sup></small>C <span class="italic">δ</span> = 77.16 ppm; dichloromethane <small><sup>1</sup></small>H <span class="italic">δ</span> = 5.32 ppm, <small><sup>13</sup></small>C <span class="italic">δ</span> = 54.00 ppm; DMSO <small><sup>1</sup></small>H <span class="italic">δ</span> = 2.50 ppm, <small><sup>13</sup></small>C <span class="italic">δ</span> = 39.52 ppm). Infrared spectra were recorded using Thermo Fisher Nicolet iS50 FT-IR spectrometer with attenuated total reflectance (ATR) unit. Low- and high-resolution mass spectroscopy (LR- and HR-MS) analysis was conducted with mass spectrometer equipped with deep exposure probe (Bruker MS-320, GCMS or DEPMS mode) and electrospray ionization (ESI) time of flight (TOF) mass detector (ABSciex QTOF 5600), respectively. ESI-HRMS spectra were recorded in negative or positive ionization modes and the analytes were dissolved in HPLC grade ACN or 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 DCM<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>methanol mixture. Elemental analysis was performed on a Thermo Scientific Flash 2000 analyzer. Chromatographic purifications were carried out with preparative flash chromatogram Isolera One from Biotage using self-packed columns with silica gel 60 Å 230–400 mesh (Merck). Celite 545 0.02–0.1 mm (Merck) was used as a Samplet® filler.</p>
<p class="otherpara">All target compounds were screened for antibacterial and antifungal activities by micro-dilution broth method using Mueller–Hinton broth and Mueller–Hinton broth with 5% lysed sheep blood for growth of non-fastidious and fastidious bacteria or Mueller–Hinton broth with 2% glucose for growth of fungi. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the tested compounds were evaluated for the panel of the reference microorganism from American Type Culture Collection (ATCC), including <span class="italic">Escherichia coli</span> ATCC25922, <span class="italic">Salmonella typhimurium</span> ATCC14028, <span class="italic">Klebsiella pneumoniae</span> ATCC13883, <span class="italic">Pseudomonas aeruginosa</span> ATCC9027 and <span class="italic">Proteus mirabilis</span> ATCC12453 were selected as exemplary Gram-negative bacteria; <span class="italic">Staphylococcus aureus</span> ATCC25923, <span class="italic">Staphylococcus aureus</span> ATCC6538, <span class="italic">Staphylococcus aureus</span> ATCC43300, <span class="italic">Staphylococcus epidermidis</span> ATCC12228, <span class="italic">Micrococcus luteus</span> ATCC10240, <span class="italic">Bacillus subtilis</span> ATCC6633, <span class="italic">Bacillus cereus</span> ATCC10876, <span class="italic">Streptococcus pyogenes</span> ATCC19615, <span class="italic">Streptococcus pneumoniae</span> ATCC49619 and <span class="italic">Streptococcus mutans</span> ATCC25175 as Gram-positive bacteria; and <span class="italic">Candida albicans</span> ATCC10231, <span class="italic">Candida albicans</span> ATCC2091, <span class="italic">Candida parapsilosis</span> ATCC22019, <span class="italic">Candida glabrata</span> ATCC 90030 and <span class="italic">Candida crusei</span> ATCC14243 as yeast. A detailed procedure for the determination of the MIC and MBC value has been presented in the earlier publication.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a></p>
<p class="otherpara">Human histiocytic lymphoma cell line U-937 (obtained from American Type Culture Collection), human T-cell lymphoma HUT-78 and human normal B lymphocytes COLO-720L (obtained from European Collection of Authenticated Cell Cultures) were cultured in suspension in RPMI 1640 containing 5% FBS and 0.01% penicillin–streptomycin. Stock solution of compounds <strong>1–12</strong> were diluted with DMSO to the required concentration.</p>
<p class="otherpara">The MTT tetrazolium salt colorimetric assay was used to detect cytotoxicity of compounds <strong>1–12</strong>. Cells were cultured in 96-well plates in amount of 0.2 × 10<small><sup>6</sup></small> U-937 cells per well in a volume of 0.2 mL. After incubation 50 μL MTT solution (5 mg mL<small><sup>−1</sup></small>) in sterile water was applied to each well and left for 2 h incubation at 37 °C. Then 0.4 mL of dimethylsulfoxide (DMSO) was added to each Eppendorf tube and left for 5 min. After centrifugation the optical density of the supernatant at 570 nm was read. Data were expressed as mean ± SD of at least 5 independent experiments.</p>
<p class="otherpara">Based on the results of the cell survival presented in this paper, the values of the median lethal dose (LD<small><sub>50</sub></small> median lethal dose) for cells were calculated using Behrens' method<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> with the following assumptions: the number of cells per measurement point is constant, and the absorbance determined in the MTT method is correlated with the number of live cells. Besides, if the cell is experiencing a higher dose, it has survived all lower doses; if the cell dies at the lower dose, it would die at all higher doses. Then, the percentage of mortality was calculated for each dose of the compound and LD<small><sub>50</sub></small> values were obtained from appropriate graphs.</p>
<p class="otherpara">Pre-coated PAMPA Plate System Gentest™ was purchased from Corning, Tewksbury, MA, USA. The stock solutions of <strong>5a</strong>, <strong>5b</strong>, <strong>5c</strong> and caffeine (10 mM) were prepared in DMSO. Before the assay the examined compounds were diluted in PBS buffer (pH 7.4) to 200 μM and added to the donor wells (300 μL per well). The PBS buffer was added to the acceptor wells (200 μL per well). Each compound was tested in triplicate. The plate was incubated next at room temperature without shaking for five hours. The solutions from donor and acceptor wells were analyzed by LC/MS Waters ACQUITY™ TQD system with the TQ Detector (Waters, Milford, USA). The analyte/internal standard (IS) peak height ratios were used to determine the concentrations of caffeine (CFN) in donor and acceptor wells. The permeability coefficient (<span class="italic">P</span><small><sub>e</sub></small>, cm s<small><sup>−1</sup></small>) was calculated using the following formula: <span class="italic">P</span><small><sub>e</sub></small> = {−ln[1 − <span class="italic">C</span><small><sub>A</sub></small>/<span class="italic">C</span><small><sub>eq</sub></small>]}/[<span class="italic">A</span> × <span class="italic">t</span> × (1/<span class="italic">V</span><small><sub>D</sub></small> + 1/<span class="italic">V</span><small><sub>A</sub></small>)] where: <span class="italic">A</span> = filter area (0.3 cm<small><sup>2</sup></small>), <span class="italic">V</span><small><sub>D</sub></small> = donor well volume (0.3 mL), <span class="italic">V</span><small><sub>A</sub></small> = acceptor well volume (0.2 mL), <span class="italic">t</span> = incubation time (s), <span class="italic">C</span><small><sub>A</sub></small> = compound concentration in the acceptor well after incubation, <span class="italic">C</span><small><sub>D</sub></small> = compound concentration in the donor well after incubation, <span class="italic">C</span><small><sub>eq</sub></small> = [<span class="italic">C</span><small><sub>D</sub></small> × <span class="italic">V</span><small><sub>D</sub></small> + <span class="italic">C</span><small><sub>A</sub></small> × <span class="italic">V</span><small><sub>A</sub></small>]/(<span class="italic">V</span><small><sub>D</sub></small> + <span class="italic">V</span><small><sub>A</sub></small>).</p>

<h3 id="sect789"><span class="b_heading">General procedure for the synthesis of <strong>1a</strong>, <strong>1b</strong> and <strong>1c</strong></span></h3>
<span>A 100 mL Schlenk flask was loaded with 4-(diphenylamino)phenylboronic acid, aryl bromoaldehyde and dichlorobis(triphenylophosphine)palladium(<span class="small_caps">II</span>). Subsequently, the flask was evacuated and backfilled with argon three times. Next, toluene, ethanol and deoxygenated aqueous potassium carbonate solution was added. The reaction mixture was vigorously stirred at 90 °C for 6 h. After complete consumption of bromoaldehyde confirmed by GC-MS, the volume of the organic phase was almost completely reduced under reduced pressure. Then, 20 mL of DCM was added and water phase was removed. The organic phase was washed three times with 50 mL of water and evaporated to dryness under reduced pressure. The residue was adsorbed on Celite and loaded into a Biotage Samplet®. The product was purified by column chromatography using gradient elution from 100% hexanes to 60% DCM<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>40% hexanes. The fractions containing desired product were collected and concentrated under reduced pressure. The residue was recrystallized by slow evaporation from DCM<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>hexanes and subsequently washed twice with pentane.</span>

<h3 id="sect796"><span class="b_heading">4′-(Diphenylamino)-[1,1′-biphenyl]-4-carbaldehyde (<strong>1a</strong>)</span></h3>
<span>The product was synthesized according to the general procedure, using the following substances: 4-(diphenylamino)phenylboronic acid (1.272 g, 4.40 mmol), 4-bromobenzaldehyde (0.74 g, 4.0 mmol), dichlorobis(triphenylophosphine)palladium(<span class="small_caps">II</span>) (28.0 mg, 0.04 mmol), 2 M potassium carbonate aqueous solution (11.99 mL, 23.96 mmol), 23 mL of toluene 7.6 mL of ethanol. The product was obtained as yellow needles (1.36 g, 3.90 mmol). Yield: 90%. <small><sup>1</sup></small>H NMR (300 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 10.02 (s, 1H), 7.92 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.75 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.55 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.36–7.23 (m, 4H), 7.18–7.02 (m, 8H). <small><sup>13</sup></small>C NMR (75 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 192.20, 149.00, 147.93, 146.97, 135.40, 133.30, 130.72, 129.95, 128.54, 127.39, 125.45, 124.05, 123.57. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1690 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O). MS (DEP-LRMS): 350.3 (28.0%), 349.2 (100.0%). MS (ESI-HRMS): calculated for [C<small><sub>25</sub></small>H<small><sub>20</sub></small>NO]<small><sup>+</sup></small> 350.1539, measured 350.1565 (error 7.4 ppm).</span>

<h3 id="sect818"><span class="b_heading">4-(4-(Diphenylamino)phenyl)-1-naphthalenecarbaldehyde (<strong>1b</strong>)</span></h3>
<span>The product was synthesized according to the general procedure, using the following substances: 4-(diphenylamino)phenylboronic acid (1.178 g, 4.08 mmol), 4-bromo-1-naphthalenecarbaldehyde (0.871 g, 3.71 mmol), dichlorobis(triphenylophosphine)palladium(<span class="small_caps">II</span>) (26.0 mg, 0.037 mmol), 2 M potassium carbonate aqueous solution (11.12 mL, 23.96 mmol), 22 mL of toluene 7 mL of ethanol. The product was obtained as yellow powder (1.05 g, 2.63 mmol). Yield: 71%. <small><sup>1</sup></small>H NMR (300 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 10.40 (s, 1H), 9.34 (d, <span class="italic">J</span> = 7.6 Hz, 1H), 8.13 (d, <span class="italic">J</span> = 8.4 Hz, 1H), 8.03 (d, <span class="italic">J</span> = 7.4 Hz, 1H), 7.71 (t, <span class="italic">J</span> = 6.9 Hz, 1H), 7.65–7.53 (m, 2H), 7.42–7.26 (m, 6H), 7.24–7.14 (m, 6H), 7.09 (t, <span class="italic">J</span> = 7.3 Hz, 2H). <small><sup>13</sup></small>C NMR (75 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 193.74, 148.51, 148.11, 147.70, 136.88, 133.82, 132.56, 131.73, 131.30, 130.85, 129.95, 129.25, 127.40, 127.36, 126.60, 125.48, 125.37, 123.92, 123.28. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1680 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O). MS (DEP-LRMS): 400.3 (31.4%), 399.3 (100%). MS (ESI-HRMS): calculated for [C<small><sub>29</sub></small>H<small><sub>22</sub></small>NO]<small><sup>+</sup></small> 400.1696, measured 400.1728 (error 8.0 ppm).</span>

<h3 id="sect842"><span class="b_heading">10-(4-(Diphenylamino)phenyl)anthracene-9-carbaldehyde (<strong>1c</strong>)</span></h3>
<span>The product was synthesized according to the general procedure, using the following substances: 4-(diphenylamino)phenylboronic acid (0.829 g, 2.87 mmol), 10-bromo-9-anthracenecarbaldehyde (0.743 g, 2.61 mmol), dichlorobis(triphenylophosphine)palladium(<span class="small_caps">II</span>) (18.0 mg, 0.026 mmol), 2 M potassium carbonate aqueous solution(7.82 mL, 15.63 mmol), 15 mL of toluene 5 mL of ethanol. The product was obtained as orange powder (1.06 g, 2.36 mmol). Yield: 90%. <small><sup>1</sup></small>H NMR (300 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 11.55 (s, 1H), 9.00 (d, <span class="italic">J</span> = 9.0 Hz, 2H), 7.90 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.73–7.62 (m, 2H), 7.53–7.42 (m, 2H), 7.41–7.31 (m, 4H), 7.30–7.22 (m, 8H), 7.10 (t, <span class="italic">J</span> = 7.2 Hz, 2H). <small><sup>13</sup></small>C NMR (75 MHz, CD<small><sub>2</sub></small>Cl<small><sub>2</sub></small>) <span class="italic">δ</span> 193.79, 148.32, 148.20, 146.06, 132.20, 132.09, 132.01, 130.68, 129.98, 129.08, 128.67, 125.98, 125.53, 125.36, 124.00, 123.90, 123.29. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1664 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O). MS (DEP-LRMS): 450.3 (36.2%), 449.3 (100.0%). MS (ESI-HRMS): calculated for [C<small><sub>33</sub></small>H<small><sub>24</sub></small>NO]<small><sup>+</sup></small> 450.1852, measured 400.1876 (error 5.3 ppm).</span>

<h3 id="sect864"><span class="b_heading">Rhodanine (<strong>2a</strong>)</span></h3>
<span>A solution of chloroacetic acid (23.62 g, 0.25 mol) and ammonium thiocyanate (38.06 g, 0.50 mol) in 150 mL of water was heated for 20 minutes under reflux. After cooling down, a precipitate was formed. The crude product was filtered and recrystallized from water. The product was obtained as a yellowish powder (14.96 g, 0.113 mol), yield: 45%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 13.14 (s, 1H), 4.26 (s, 2H). <small><sup>13</sup></small>C NMR (75 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 205.43, 176.81, 39.42. MS (ESI-HRMS): calculated for [C<small><sub>3</sub></small>H<small><sub>2</sub></small>NOS<small><sub>2</sub></small>]<small><sup>−</sup></small> 131.9583, measured 131.9572 (error 8.3 ppm).</span>

<h3 id="sect880"><span class="b_heading">Rhodanine-3-acetic acid (<strong>2b</strong>)</span></h3>
<span>A solution of potassium hydroxide (28.00 g, 0.5 mol) in 100 mL of water was added to the suspension of aminoethanoic acid (18.75 g, 0.25 mol). The resulting solution was cooled to 5 °C and carbon disulfide (19.03 g, 0.25 mol) was added. The content of the flask was mixed at 5 °C for 6 h. The cooling bath was removed and mixing was continued at room temperature for 20 h. Then, a solution of chloroacetic acid (23.62 g, 0.25 mol) in 100 mL of water was added. The reaction mixture was stirred for 8 h at the temperature below 15 °C. Next, a mixture of 150 mL concentrated hydrochloric acid and 200 mL of water was added slowly. The resulting mixture was heated at 90 °C for 25 min. After cooling down, a precipitate was formed, which was next filtered and recrystallized from water. The product was obtained as a white crystalline solid (21.49 g, 0.275 mol), yield: 55%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 4.55 (s, 2H), 4.40 (s, 2H). <small><sup>13</sup></small>C NMR (75 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 202.96, 173.88, 167.47, 44.90, 36.08. MS (ESI-HRMS): calculated for [C<small><sub>5</sub></small>H<small><sub>4</sub></small>NO<small><sub>3</sub></small>S<small><sub>2</sub></small>]<small><sup>−</sup></small> 189.9638, measured 189.9625 (error 6.8 ppm).</span>

<h3 id="sect897"><span class="b_heading">1-Acetyl-2-thiohydantoin (<strong>3a</strong>)</span></h3>
<span>A flask containing a mixture of aminoethanoic acid (37.5 g, 0.5 mol), ammonium thiocyanate (38.06 g, 0.5 mol), 150 mL of acetic anhydride and 15 mL of acetic acid was heated in a water bath at 110 °C for 30 minutes under reflux. Next, the flask was cooled to 60 °C and heated again at 100 °C for 15 minutes. Then, the reaction mixture was poured into a beaker containing 1000 mL of cold water. The resulting precipitate was filtered and recrystallized from acetic acid. The product was obtained as a brown crystalline solid (55.3 g, 0.35 mol), yield: 70%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.58 (s, 1H), 4.39 (s, 2H), 2.67 (s, 3H). <small><sup>13</sup></small>C NMR (75 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 182.57, 170.46, 169.44, 52.26, 26.70, 26.67. MS (ESI-HRMS): calculated for [C<small><sub>5</sub></small>H<small><sub>5</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>S]<small><sup>−</sup></small> 157.0077, measured 157.0052 (error 15.9 ppm).</span>

<h3 id="sect914"><span class="b_heading">2-Thiohydantoin-3-acetic acid (<strong>3b</strong>)</span></h3>
<span>A solution of sodium hydroxide (12.0 g, 0.3 mol) was added to a well stirred suspension of aminoethanoic acid (18.75 g, 0.25 mol) in 20 mL of water. To the resulting solution carbon disulfide (11.42 g, 0.15 mol) was added under nitrogen atmosphere and the reaction mixture was refluxed for 8 h. After the heating was finished, the excess of carbon disulfide was evaporated on a rotary evaporator. Next, a mixture of 100 mL of concentrated hydrochloric acid and 200 mL of water was added. The resulting mixture was refluxed for 2 h. After cooling, a precipitate was formed, which was filtered and subsequently recrystallized from water. The product was obtained as a white crystalline solid (39.15 g, 0.225 mol), yield: 75%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 10.34 (s, 1H), 4.34 (s, 2H), 4.23 (d, <span class="italic">J</span> = 1.3 Hz, 2H). <small><sup>13</sup></small>C NMR (75 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 182.87, 172.27, 168.44, 48.64, 41.47. MS (ESI-HRMS): calculated for [C<small><sub>5</sub></small>H<small><sub>5</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>S]<small><sup>−</sup></small> 173.0026, measured 173.0008 (error 10.4 ppm).</span>

<h3 id="sect932"><span class="b_heading">General procedure for the synthesis of <strong>4a–7c</strong></span></h3>
<span><strong>1a</strong> (0.1 g, 0.286 mmol), <strong>1b</strong> (0.114 g, 0.286 mmol) or <strong>1c</strong> (0.129 g, 0.286 mmol), respective rhodanine (0.046 g, 0.343 mmol), rhodanine-3-acetic acid (0.066 g, 0.343 mmol), 1-acetyl-2-thiohydantoin (0.054 g, 0.343 mmol) or 2-thiohydantoin-3-acetic acid (0.06 g, 0.343 mmol) and ammonium acetate (44 mg, 0.57 mmol) were added to a CEM microwave vial. Subsequently, 2 mL of AA was added and the vessel was closed with a cap. The mixture was heated with maximum power 200 W at 180 °C for 5–7 min (5 min with <strong>1a</strong>, 6 min with <strong>1b</strong> and 7 min with <strong>1c</strong>). During heating the color of the mixtures turned red very quickly and became homogenous. After cooling back to room temperature the precipitate was formed (some products tended to form supercooled solutions, in that case precipitation was initiated by ultrasonification). The solid was centrifuged and the supernatant was sucked off with a syringe. The solid was washed with 1 mL of AA and 4 times with 4 mL portions of water in the same manner. The obtained product was dried in an oven at 110 °C overnight. In some cases the product was purified by subsequent recrystallization from 2-propanol.</span>

<h3 id="sect942"><span class="b_heading">(<span class="italic">Z</span>)-5-((4′-(Diphenylamino)-(1,1′-biphenyl)-4-yl)methylene)-2-thioxothiazolidin-4-one (<strong>4a</strong>)</span></h3>
<span>Brick-red crystalline solid (128 mg, 0.276 mmol). Yield: 96%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 7.79 (d, <span class="italic">J</span> = 8.2 Hz, 2H), 7.71–7.55 (m, 5H), 7.33 (t, <span class="italic">J</span> = 7.8 Hz, 4H), 7.14–6.95 (m, 8H). <small><sup>13</sup></small>C NMR (75 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 195.64, 169.62, 147.75, 146.89, 141.66, 132.02, 131.50, 131.42, 129.84, 127.94, 126.90, 124.86, 124.72, 123.82, 122.64. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1689 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1068 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>28</sub></small>H<small><sub>19</sub></small>N<small><sub>2</sub></small>OS<small><sub>2</sub></small>]<small><sup>−</sup></small> 463.0944, measured 463.0947 (error 0.6 ppm).</span>

<h3 id="sect965"><span class="b_heading">(<span class="italic">Z</span>)-5-((4-(4-(Diphenylamino)phenyl)naphthalen-1-yl)methylene)-2-thioxothiazolidin-4-one (<strong>4b</strong>)</span></h3>
<span>Dark-brown crystalline solid (139 mg, 0.270 mmol). Yield: 94%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 8.31 (s, 1H), 8.23 (d, <span class="italic">J</span> = 8.4 Hz, 1H), 8.01 (d, <span class="italic">J</span> = 8.1 Hz, 1H), 7.75–7.53 (m, 4H), 7.45–7.30 (m, 6H), 7.18–7.04 (m, 8H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 196.17, 168.97, 147.16, 146.97, 142.33, 132.77, 131.66, 131.19, 130.85, 129.75, 129.34, 128.60, 128.17, 127.52, 127.17, 126.68, 126.63, 126.57, 124.58, 123.93, 123.60, 122.26. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1683 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1073 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>32</sub></small>H<small><sub>21</sub></small>N<small><sub>2</sub></small>OS<small><sub>2</sub></small>]<small><sup>−</sup></small> 513.1101, measured 513.1103 (error 0.4 ppm).</span>

<h3 id="sect988"><span class="b_heading">(<span class="italic">Z</span>)-5-((10-(4-(Diphenylamino)phenyl)anthracen-9-yl)methylene)-2-thioxothiazolidin-4-one (<strong>4c</strong>)</span></h3>
<span>Orange powder (145 mg, 0.257 mmol). Yield: 90%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 8.52 (s, 1H), 8.10 (d, <span class="italic">J</span> = 8.6 Hz, 2H), 7.75 (d, <span class="italic">J</span> = 8.7 Hz, 2H), 7.68–7.58 (m, 2H), 7.58–7.47 (m, 2H), 7.39 (t, <span class="italic">J</span> = 7.9 Hz, 4H), 7.30 (d, <span class="italic">J</span> = 8.5 Hz, 2H), 7.24–7.08 (m, 8H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 147.24, 132.02, 129.97, 129.56, 127.88, 127.42, 127.04, 126.27, 125.58, 124.76, 124.70, 123.78, 122.36. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1734 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1068 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>36</sub></small>H<small><sub>23</sub></small>N<small><sub>2</sub></small>OS<small><sub>2</sub></small>]<small><sup>−</sup></small> 563.1257, measured 563.1259 (error 0.4 pm).</span>

<h3 id="sect1013"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((4′-(Diphenylamino)-(1,1′-biphenyl)-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (<strong>5a</strong>)</span></h3>
<span>Red powder (140 mg, 0.268 mmol). Yield: 94%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 7.90 (s, 1H), 7.84 (d, <span class="italic">J</span> = 8.3 Hz, 2H), 7.70 (dd, <span class="italic">J</span> = 8.5, 6.3 Hz, 4H), 7.34 (t, <span class="italic">J</span> = 7.8 Hz, 4H), 7.15–7.04 (m, 6H), 7.02 (d, <span class="italic">J</span> = 8.6 Hz, 2H), 4.74 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO) <span class="italic">δ</span> 193.21, 167.49, 166.56, 147.89, 146.88, 142.17, 133.79, 131.89, 131.76, 131.28, 129.87, 128.01, 127.01, 124.80, 123.90, 122.56, 121.12, 45.19. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1722 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1701 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1056 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>30</sub></small>H<small><sub>21</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>S<small><sub>2</sub></small>]<small><sup>−</sup></small> 521.0999, measured 521.0994 (error 1.0 ppm).</span>

<h3 id="sect1037"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((4-(4-(Diphenylamino)phenyl)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (<strong>5b</strong>)</span></h3>
<span>Orange crystalline solid (148 mg, 0.258 mmol). Yield: 90%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 8.55 (s, 1H), 8.26 (d, <span class="italic">J</span> = 8.3 Hz, 1H), 8.02 (d, <span class="italic">J</span> = 8.3 Hz, 1H), 7.79 (d, <span class="italic">J</span> = 7.6 Hz, 1H), 7.75–7.61 (m, 2H), 7.59 (d, <span class="italic">J</span> = 7.6 Hz, 1H), 7.45–7.31 (m, 6H), 7.17–7.04 (m, 8H), 4.78 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 193.84, 167.51, 166.03, 147.34, 147.06, 142.95, 132.76, 131.79, 131.32, 130.97, 130.73, 129.89, 129.21, 127.82, 127.41, 127.18, 126.79, 126.73, 124.95, 124.73, 124.09, 123.78, 122.29, 45.22. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1725 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1708 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1062 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>34</sub></small>H<small><sub>23</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>S<small><sub>2</sub></small>]<small><sup>−</sup></small> 571.1156, measured 571.1137 (error 3.3 ppm).</span>

<h3 id="sect1063"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((10-(4-(Diphenylamino)phenyl)anthracen-9-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (<strong>5c</strong>)</span></h3>
<span>Red crystalline solid (159 mg, 0.255 mmol). Yield: 89%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 8.83 (s, 1H), 8.06 (d, <span class="italic">J</span> = 8.7 Hz, 2H), 7.76 (d, <span class="italic">J</span> = 8.7 Hz, 2H), 7.69–7.58 (m, 2H), 7.59–7.48 (m, 2H), 7.38 (t, <span class="italic">J</span> = 7.8 Hz, 4H), 7.28 (d, <span class="italic">J</span> = 8.5 Hz, 2H), 7.23–7.07 (m, 8H), 4.79 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 193.63, 167.57, 165.05, 147.18, 139.73, 132.57, 131.94, 131.10, 130.85, 129.92, 129.53, 127.89, 127.51, 127.27, 126.99, 126.31, 125.30, 124.76, 123.75, 122.25, 45.29. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1727 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1713 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1056 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>38</sub></small>H<small><sub>25</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>S<small><sub>2</sub></small>]<small><sup>−</sup></small> 621.1312, measured 621.1289 (error 3.7 ppm).</span>

<h3 id="sect1089"><span class="b_heading">(<span class="italic">Z</span>)-5-((4′-(Diphenylamino)-(1,1′-biphenyl)-4-yl)methylene)-2-thioxoimidazolidin-4-one (<strong>6a</strong>)</span></h3>
<span>Orange crystalline solid (92 mg, 0.206 mmol). Yield: 72%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.38 (s, 1H), 12.20 (s, 1H), 7.80 (d, <span class="italic">J</span> = 8.2 Hz, 2H), 7.67 (t, <span class="italic">J</span> = 8.2 Hz, 4H), 7.33 (t, <span class="italic">J</span> = 7.8 Hz, 4H), 7.13–6.97 (m, 8H), 6.51 (s, 1H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 179.17, 166.05, 147.45, 147.05, 140.32, 132.81, 131.06, 129.88, 127.83, 127.61, 126.46, 124.59, 123.73, 123.05, 111.63. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1720 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1080 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>28</sub></small>H<small><sub>20</sub></small>N<small><sub>3</sub></small>OS]<small><sup>−</sup></small> 446.1333, measured 446.1321 (error 2.7 ppm).</span>

<h3 id="sect1112"><span class="b_heading">(<span class="italic">Z</span>)-5-((4-(4-(Diphenylamino)phenyl)naphthalen-1-yl)methylene)-2-thioxoimidazolidin-4-one (<strong>6b</strong>)</span></h3>
<span>Yellow crystalline solid (122 mg, 0.245 mmol). Yield: 86%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.34 (s, 2H), 8.15 (d, <span class="italic">J</span> = 8.2 Hz, 1H), 7.98 (d, <span class="italic">J</span> = 7.9 Hz, 1H), 7.85 (d, <span class="italic">J</span> = 7.5 Hz, 1H), 7.70–7.53 (m, 2H), 7.49 (d, <span class="italic">J</span> = 7.5 Hz, 1H), 7.45–7.31 (m, 6H), 7.17–7.05 (m, 9H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 130.99, 129.93, 124.64, 123.72. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1714 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1087 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>32</sub></small>H<small><sub>22</sub></small>N<small><sub>3</sub></small>OS]<small><sup>−</sup></small> 496.1489, measured 496.1465 (error 4.8 ppm).</span>

<h3 id="sect1136"><span class="b_heading">(<span class="italic">Z</span>)-5-((10-(4-(Diphenylamino)phenyl)anthracen-9-yl)methylene)-2-thioxoimidazolidin-4-one (<strong>6c</strong>)</span></h3>
<span>The pure product was obtained after recrystallization from 2-propanol. Red crystalline solid (116 mg, 0.212 mmol). Yield: 74%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.37 (s, 1H), 11.67 (s, 1H), 8.06 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.74 (d, <span class="italic">J</span> = 8.6 Hz, 2H), 7.62–7.46 (m, 4H), 7.46–7.35 (m, 4H), 7.34–7.25 (m, 3H), 7.22 (d, <span class="italic">J</span> = 7.1 Hz, 6H), 7.12 (t, <span class="italic">J</span> = 7.3 Hz, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 179.13, 164.64, 147.15, 146.88, 137.76, 133.63, 131.86, 131.51, 129.79, 129.64, 129.08, 127.09, 126.77, 126.18, 125.85, 125.68, 124.57, 123.54, 122.38, 108.17. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1742 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1099 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>36</sub></small>H<small><sub>24</sub></small>N<small><sub>3</sub></small>OS]<small><sup>−</sup></small> 546.1646, measured 546.1629 (error 3.1 ppm).</span>

<h3 id="sect1160"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((4′-(Diphenylamino)-(1,1′-biphenyl)-4-yl)methylene)-4-oxo-2-thioxoimidazolidin-3-yl)acetic acid (<strong>7a</strong>)</span></h3>
<span>Orange crystalline solid (122 mg, 0.241 mmol). Yield: 84%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.58 (s, 1H), 7.85 (d, <span class="italic">J</span> = 8.2 Hz, 2H), 7.72 (d, <span class="italic">J</span> = 8.2 Hz, 2H), 7.68 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.34 (t, <span class="italic">J</span> = 7.7 Hz, 4H), 7.15–6.97 (m, 8H), 6.72 (s, 1H), 4.51 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 178.26, 168.37, 163.78, 147.49, 147.00, 140.67, 132.65, 131.27, 130.76, 129.84, 127.84, 126.47, 125.72, 124.60, 124.58, 123.73, 122.93, 113.61, 41.97. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1735 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1647 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1076 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>30</sub></small>H<small><sub>22</sub></small>N<small><sub>3</sub></small>O<small><sub>3</sub></small>S]<small><sup>−</sup></small> 504.1387, measured 504.1383 (error 0.8 ppm).</span>

<h3 id="sect1185"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((4-(4-(Diphenylamino)phenyl)naphthalen-1-yl)methylene)-4-oxo-2-thioxoimidazolidin-3-yl)acetic acid (<strong>7b</strong>)</span></h3>
<span>Yellow powder (135 mg, 0.243 mmol). Yield: 85%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 8.17 (d, <span class="italic">J</span> = 8.2 Hz, 1H), 7.99 (d, <span class="italic">J</span> = 8.3 Hz, 1H), 7.88 (d, <span class="italic">J</span> = 7.5 Hz, 1H), 7.70–7.55 (m, 2H), 7.52 (d, <span class="italic">J</span> = 7.5 Hz, 1H), 7.44–7.29 (m, 7H), 7.17–7.05 (m, 8H), 4.54 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO) <span class="italic">δ</span> 178.48, 168.44, 163.38, 147.15, 147.09, 141.08, 133.36, 131.75, 131.19, 130.94, 129.88, 128.57, 128.37, 128.14, 127.25, 126.86, 126.73, 126.48, 124.63, 124.58, 124.38, 123.69, 123.64, 122.59, 122.53, 110.33, 42.00. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1707 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1649 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1073 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>34</sub></small>H<small><sub>24</sub></small>N<small><sub>3</sub></small>O<small><sub>3</sub></small>S]<small><sup>−</sup></small> 554.1544, measured 554.1527 (error 3.1 ppm).</span>

<h3 id="sect1208"><span class="b_heading">(<span class="italic">Z</span>)-2-(5-((10-(4-(Diphenylamino)phenyl)anthracen-9-yl)methylene)-4-oxo-2-thioxoimidazolidin-3-yl)acetic acid (<strong>7c</strong>)</span></h3>
<span>The pure product was obtained after recrystallization from 2-propanol. Orange powder (128 mg, 0.211 mmol). Yield: 74%. <small><sup>1</sup></small>H NMR (300 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 12.09 (s, 1H), 8.05 (d, <span class="italic">J</span> = 8.6 Hz, 2H), 7.76 (d, <span class="italic">J</span> = 8.6 Hz, 2H), 7.64–7.48 (m, 5H), 7.40 (t, <span class="italic">J</span> = 7.7 Hz, 4H), 7.33–7.26 (m, 2H), 7.25–7.17 (m, 6H), 7.12 (t, <span class="italic">J</span> = 7.3 Hz, 2H), 4.55 (s, 2H). <small><sup>13</sup></small>C NMR (151 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 178.29, 172.10, 168.35, 162.43, 147.16, 146.93, 138.11, 131.85, 131.81, 131.42, 129.81, 129.66, 129.09, 127.15, 126.36, 125.76, 125.69, 124.61, 123.58, 122.36, 110.38, 41.85. IR (ATR, <span class="italic">ν</span><small><sub>max</sub></small>, cm<small><sup>−1</sup></small>): 1718 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1643 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O), 1075 (C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>S). MS (ESI-HRMS): calculated for [C<small><sub>38</sub></small>H<small><sub>26</sub></small>N<small><sub>3</sub></small>O<small><sub>3</sub></small>S]<small><sup>−</sup></small> 604.1700, measured 604.1692 (error 1.3 ppm).</span>


<h2 id="sect1233"><span class="a_heading">Conflicts of interest</span></h2>
<span>There are no conflicts of interest to declare.</span>


<h2 id="sect1237"><span class="a_heading">Acknowledgements</span></h2><span>The research was partially financed from the Polish Statutory Research Projects K/ZDS/007886 and BS-465/G/2018.</span>
<span id="sect1239"><h2 id="sect1236"><span class="a_heading">Notes and references</span></h2></span><ol type="1"><li><span id="cit1">S. N. Farouk, <span class="italic">J. Adv. Microbiol.</span>, 2017, <span class="bold">7</span>, 1 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Adv.%20Microbiol.%5BJour%5D%20AND%207%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit2">M. Exner, S. Bhattacharya, B. Christiansen, J. Gebel, P. Goroncy-Bermes, P. Hartemann, P. Heeg, C. Ilschner, A. Kramer, E. Larson, W. Merkens, M. Mielke, P. Oltmanns, B. Ross, M. Rotter, R. M. Schmithausen, H. G. Sonntag and M. Trautmann, <span class="italic">GMS Hyg. Infect. Control</span>, 2017, <span class="bold">12</span>, Doc05, <small> DOI:<a class="DOILink" href="https://doi.org/10.3205/dgkh000290" TARGET="_BLANK" title="DOI Link to 10.3205/dgkh000290">10.3205/dgkh000290</a></small>.</span></li><li><span id="cit3">K. C. Huanga, R. Mukhopadhyay, B. Wena, Z. Gitaia and N. S. Wingreena, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2008, <span class="bold">105</span>, 19282 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.0805309105" title="DOI Link to resource 10.1073/pnas.0805309105">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19050072%5Buid%5D" title="PubMed Link to resource 19050072">PubMed</a>.</span></li><li><span id="cit4">N. Kashef, Y. Y. Huang and M. R. Hamblin, <span class="italic">Nanophotonics</span>, 2017, <span class="bold">6</span>, 853 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksLzE" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit5">S. I. Miller and N. R. Salama, <span class="italic">PLoS Biol.</span>, 2018, <span class="bold">16</span>, e2004935 <a target="_blank" class="DOILink" href="https://doi.org/10.1371/journal.pbio.2004935" title="DOI Link to resource 10.1371/journal.pbio.2004935">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29342145%5Buid%5D" title="PubMed Link to resource 29342145">PubMed</a>.</span></li><li><span id="cit6">K. Li, X. X. Yuan, H. M. Sun, L. S. Zhao, R. Tang, Z. H. Chen, Q. L. Qin, X. L. Chen, Y. Z. Zhang and H. N. Su, <span class="italic">Microbiology</span>, 2018, <span class="bold">9</span>, 620, <small> DOI:<a class="DOILink" href="https://doi.org/10.3389/fmicb.2018.00620" TARGET="_BLANK" title="DOI Link to 10.3389/fmicb.2018.00620">10.3389/fmicb.2018.00620</a></small>.</span></li><li><span id="cit7">A. Al-Mulla, <span class="italic">Der Pharma Chem.</span>, 2017, <span class="bold">9</span>, 141 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXitVSqsbzJ" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit8">R. Kumar and S. Patil, <span class="italic">Hygeia J. Drugs Med.</span>, 2017, <span class="bold">9</span>, 80 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXltFKrsro%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit9">S. K. Manjal, R. Kaur, R. Bhatia, K. Kumar, V. Singh, R. Shankar, R. Kaur and R. K. Rawal, <span class="italic">Bioorg. Chem.</span>, 2017, <span class="bold">75</span>, 406 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bioorg.2017.10.014" title="DOI Link to resource 10.1016/j.bioorg.2017.10.014">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29102723%5Buid%5D" title="PubMed Link to resource 29102723">PubMed</a>.</span></li><li><span id="cit10">S. Vengurlekar, R. Sharma and T. Trivedi, <span class="italic">Lett. Drug Des. Discov.</span>, 2012, <span class="bold">9</span>, 549 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/157018012800389322" title="DOI Link to resource 10.2174/157018012800389322">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xmt1KntrY%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit11">D. Kaminskyy, A. Kryshchyshyn and R. Lesyk, <span class="italic">Eur. J. Med. Chem.</span>, 2017, <span class="bold">140</span>, 542 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2017.09.031" title="DOI Link to resource 10.1016/j.ejmech.2017.09.031">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CmtLzI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28987611%5Buid%5D" title="PubMed Link to resource 28987611">PubMed</a>.</span></li><li><span id="cit12">M. A. Metwally and E. Abdel-Latif, <span class="italic">J. Sulfur Chem.</span>, 2012, <span class="bold">33</span>, 229 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/17415993.2011.643550" title="DOI Link to resource 10.1080/17415993.2011.643550">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XksVCnt7s%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit13">T. Mendgen, C. Steuer and C. D. Klein, <span class="italic">J. Med. Chem.</span>, 2012, <span class="bold">55</span>, 743 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm201243p" title="DOI Link to resource 10.1021/jm201243p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22077389%5Buid%5D" title="PubMed Link to resource 22077389">PubMed</a>.</span></li><li><span id="cit14">H. A. Elhady, H. S. Al-Nathali and R. El-Sayed, <span class="italic">Int. J. Adv. Res.</span>, 2017, <span class="bold">5</span>, 1716 <a target="_blank" class="DOILink" href="https://doi.org/10.21474/IJAR01/5694" title="DOI Link to resource 10.21474/IJAR01/5694">CrossRef</a>.</span></li><li><span id="cit15">C. Mathew, B. Saraswati, N. Lal and J. Varkey, <span class="italic">Int. J. Pharm. Chem.</span>, 2018, <span class="bold">8</span>, 25 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhs1yktr3P" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit16">X. Xu, R. Ge, L. Li, J. Wang, X. Lu, S. Xue, X. Chen, Z. Li and J. Bian, <span class="italic">Eur. J. Med. Chem.</span>, 2018, <span class="bold">143</span>, 1325 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2017.10.031" title="DOI Link to resource 10.1016/j.ejmech.2017.10.031">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrt73I" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29117897%5Buid%5D" title="PubMed Link to resource 29117897">PubMed</a>.</span></li><li><span id="cit17">J. Handzlik, G. Spengler, B. Mastek, A. Dela, J. Molnar, L. Amaral and K. Kieć-Konowicz, <span class="italic">Acta Pol. Pharm.</span>, 2012, <span class="bold">61</span>, 149 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Acta%20Pol.%20Pharm.%5BJour%5D%20AND%2061%5Bvolume%5D%20AND%20149%5Bpage%5D%20and%202012%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit18">A. Y. Hassan, M. M. Said, M. T. Sarg, H. S. Al-Zahabi and E. M. Hussein, <span class="italic">Life Sci.</span>, 2013, <span class="bold">10</span>, 1993 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Life%20Sci.%5BJour%5D%20AND%2010%5Bvolume%5D%20AND%201993%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit19">S. Prachand, A. K. Gupta and R. Gilhotra, <span class="italic">Int. J. Pharm. Sci. Nanotechnol.</span>, 2018, <span class="bold">11</span>, 3977 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXns12ru74%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit20">N. Daş-Evcimen, N. O. Bozdağ-Dündar, M. Sarikaya and R. Ertan, <span class="italic">J. Enzyme Inhib. Med. Chem.</span>, 2008, <span class="bold">23</span>, 297 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/14756360701475282" title="DOI Link to resource 10.1080/14756360701475282">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18569331%5Buid%5D" title="PubMed Link to resource 18569331">PubMed</a>.</span></li><li><span id="cit21">S. Rekha, U. Shantharam and C. Vineet, <span class="italic">Int. Res. J. Pharm.</span>, 2011, <span class="bold">2</span>, 81 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaks7vI" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit22">Y. Huang, Z. Guo, H. Song, Y. Liu, L. Wang and Q. Wang, <span class="italic">J. Agric. Food Chem.</span>, 2018, <span class="bold">66</span>, 8253 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.jafc.8b03087" title="DOI Link to resource 10.1021/acs.jafc.8b03087">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyqsbrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30052037%5Buid%5D" title="PubMed Link to resource 30052037">PubMed</a>.</span></li><li><span id="cit23">C. Tintori, G. Iovenitti, E. R. Ceresola, R. Ferrarese, C. Zamperini, A. Brai, G. Poli, E. Dreassi, V. Cagno, D. Lembo, F. Canducci and M. Botta, <span class="italic">PLoS One</span>, 2018, <span class="bold">13</span>, e0198478 <a target="_blank" class="DOILink" href="https://doi.org/10.1371/journal.pone.0198478" title="DOI Link to resource 10.1371/journal.pone.0198478">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29870553%5Buid%5D" title="PubMed Link to resource 29870553">PubMed</a>.</span></li><li><span id="cit24">J. Gagoria, A. Khatkar, S. Khatkar, R. Rao, K. Singh and A. Nanda, <span class="italic">Orient. J. Chem.</span>, 2008, <span class="bold">24</span>, 673 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhvFSntg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit25">N. Lopez, T. C. Jose, G. Krisnan and W. Sam, <span class="italic">Int. J. Pharm. Sci. Rev. Res.</span>, 2016, <span class="bold">41</span>, 242 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjurc%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit26">D. K. Mahapatra, D. Das, R. S. Shivhare and S. S. Borkar, <span class="italic">MOJ Bioorganic &amp; Organic Chemistry</span>, 2018, <span class="bold">2</span>, 46 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=MOJ%20Bioorganic%20&amp;%20Organic%20Chemistry%5BJour%5D%20AND%202%5Bvolume%5D%20AND%2046%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit27">C. J. R. Bataille, M. B. Brennan, S. Byrne, S. G. Davies, M. Durbin, O. Fedorov, K. V. M. Huber, A. M. Jones, S. Knapp, G. Liu, A. Nadali, C. E. Quevedo, A. J. Russell, R. G. Walker, R. Westwood and G. M. Wynne, <span class="italic">Bioorg. Med. Chem.</span>, 2017, <span class="bold">25</span>, 2657 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bmc.2017.02.056" title="DOI Link to resource 10.1016/j.bmc.2017.02.056">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXkvVSks74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28341403%5Buid%5D" title="PubMed Link to resource 28341403">PubMed</a>.</span></li><li><span id="cit28">Y. Huang, Z. Guo, H. Song, Y. Liu, L. Wang and Q. Wang, <span class="italic">J. Agric. Food Chem.</span>, 2018, <span class="bold">66</span>, 8253 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.jafc.8b03087" title="DOI Link to resource 10.1021/acs.jafc.8b03087">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyqsbrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30052037%5Buid%5D" title="PubMed Link to resource 30052037">PubMed</a>.</span></li><li><span id="cit29">J. Sivanadanam, R. Mukkamala, S. Mandal, R. Vedarajan, N. Matsumi, I. S. Aidhen and K. Ramanujam, <span class="italic">Int. J. Hydrogen Energy</span>, 2018, <span class="bold">43</span>, 4691 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijhydene.2017.10.183" title="DOI Link to resource 10.1016/j.ijhydene.2017.10.183">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXosl2rtA%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit30">D. M. Chang, D. Y. Kwon and Y. S. Kim, <span class="italic">Mol. Cryst. Liq. Cryst.</span>, 2013, <span class="bold">585</span>, 100 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/15421406.2013.850933" title="DOI Link to resource 10.1080/15421406.2013.850933">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSks7c%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit31">K. Narayanaswamy, T. Swetha, G. Kapil, S. S. Pandey, S. Hayase and S. P. Singh, <span class="italic">Electrochim. Acta</span>, 2015, <span class="bold">169</span>, 256 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.electacta.2015.04.071" title="DOI Link to resource 10.1016/j.electacta.2015.04.071">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXmsFSms7o%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit32">W. Tejchman, I. Korona-Głowniak, A. Malm, M. Żylewski and P. Suder, <span class="italic">Med. Chem. Res.</span>, 2017, <span class="bold">26</span>, 1316 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00044-017-1852-7" title="DOI Link to resource 10.1007/s00044-017-1852-7">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXksVChu7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28515623%5Buid%5D" title="PubMed Link to resource 28515623">PubMed</a>.</span></li><li><span id="cit33">T. Tomasić, N. Zidar, M. Mueller-Premru, D. Kikelj and L. P. Masic, <span class="italic">Eur. J. Med. Chem.</span>, 2010, <span class="bold">45</span>, 1667 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2009.12.030" title="DOI Link to resource 10.1016/j.ejmech.2009.12.030">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20060624%5Buid%5D" title="PubMed Link to resource 20060624">PubMed</a>.</span></li><li><span id="cit34">M. M. Sim, S. B. Ng, A. D. Buss, S. C. Crasta, K. L. Goh and S. K. Lee, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 2002, <span class="bold">12</span>, 697 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0960-894X(01)00832-0" title="DOI Link to resource 10.1016/S0960-894X(01)00832-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XhtFKqur4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11844704%5Buid%5D" title="PubMed Link to resource 11844704">PubMed</a>.</span></li><li><span id="cit35">H. A. Shindy, A. K. Khalafalla, M. M. Goma and A. H. Eed, <span class="italic">Chem. Int.</span>, 2016, <span class="bold">2</span>, 114 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2qu7rM" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit36">A. Abdel Khalek, C. R. Asby, B. A. Patel, T. T. Talele and M. N. Selem, <span class="italic">PLoS One</span>, 2016, <span class="bold">11</span>, e0164227 <a target="_blank" class="DOILink" href="https://doi.org/10.1371/journal.pone.0164227" title="DOI Link to resource 10.1371/journal.pone.0164227">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27711156%5Buid%5D" title="PubMed Link to resource 27711156">PubMed</a>.</span></li><li><span id="cit37">R. Bajpai, <span class="italic">International Journal of Engineering and Science Invention</span>, 2013, <span class="bold">2</span>, 23 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=International%20Journal%20of%20Engineering%20and%20Science%20Invention%5BJour%5D%20AND%202%5Bvolume%5D%20AND%2023%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit38">M. N. Song, X. Q. Deng, Y. R. Li, C. J. Zheng, L. Hong and H. R. Piao, <span class="italic">J. Enzyme Inhib. Med. Chem.</span>, 2014, <span class="bold">29</span>, 647 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/14756366.2013.837899" title="DOI Link to resource 10.3109/14756366.2013.837899">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsFejt73E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24102526%5Buid%5D" title="PubMed Link to resource 24102526">PubMed</a>.</span></li><li><span id="cit39">W. T. Sing, C. L. Lee, S. L. Yeo, S. P. Lim and M. M. Sim, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 2001, <span class="bold">11</span>, 91 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0960-894X(00)00610-7" title="DOI Link to resource 10.1016/S0960-894X(00)00610-7">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXotlKntw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11206478%5Buid%5D" title="PubMed Link to resource 11206478">PubMed</a>.</span></li><li><span id="cit40">N. Trotsko, U. Kosikowska, A. Paneth, M. Wujec and A. Malm, <span class="italic">Saudi Pharm. J.</span>, 2018, <span class="bold">26</span>, 568 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jsps.2018.01.016" title="DOI Link to resource 10.1016/j.jsps.2018.01.016">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29844729%5Buid%5D" title="PubMed Link to resource 29844729">PubMed</a>.</span></li><li><span id="cit41">A. F. P. Biajoli, C. S. Schwalm, J. Limberger, T. S. Claudino and A. L. Monteiro, <span class="italic">J. Braz. Chem. Soc.</span>, 2014, <span class="bold">25</span>, 2186 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCmtLbO" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit42">A. J. Burke, C. S. Marques, N. J. Turner and G. J. Hermann, <span class="italic">Active Pharmaceutical Ingredients in Synthesis: Catalytic Processes in Research and Development</span>, Wiley-VCH Verlag GmbH, Weinheim, Germany,  2018, ISBN: 978-3-527-80726-0 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Active%20Pharmaceutical%20Ingredients%20in%20Synthesis:%20Catalytic%20Processes%20in%20Research%20and%20Development%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit43">W. Wu, C. Cheng, W. Wu, H. Guo, S. Ji, P. Song, K. Han, J. Zhao, X. Zhang, Y. Wu and G. Du, <span class="italic">Eur. J. Inorg. Chem.</span>, 2010, <span class="bold">29</span>, 4683 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejic.201000327" title="DOI Link to resource 10.1002/ejic.201000327">CrossRef</a>.</span></li><li><span id="cit44">W. Guo, E. Faggi, R. M. Sebastián, A. Vallribera, R. Pleixats and A. Shafir, <span class="italic">J. Org. Chem.</span>, 2013, <span class="bold">78</span>, 8169 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo401001k" title="DOI Link to resource 10.1021/jo401001k">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsrbP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23859634%5Buid%5D" title="PubMed Link to resource 23859634">PubMed</a>.</span></li><li><span id="cit45">S. Sasaki, Y. Niko, K. Igawa and G. Konishi, <span class="italic">RSC Adv.</span>, 2014, <span class="bold">4</span>, 33474 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4RA05871B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4RA05871B">RSC</a>.</span></li><li><span id="cit46">C. Liu, Q. Ni and J. Qiu, <span class="italic">Eur. J. Org. Chem.</span>, 2011, <span class="bold">16</span>, 3009 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.201100072" title="DOI Link to resource 10.1002/ejoc.201100072">CrossRef</a>.</span></li><li><span id="cit47">X. Jin, C. J. Zheng, M. X. Song, Y. Wu, L. P. Sun, Y. J. Li, L. J. Yu and H. R. Piao, <span class="italic">Eur. J. Med. Chem.</span>, 2012, <span class="bold">56</span>, 203 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2012.08.026" title="DOI Link to resource 10.1016/j.ejmech.2012.08.026">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhsFGjt7nF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22982124%5Buid%5D" title="PubMed Link to resource 22982124">PubMed</a>.</span></li><li><span id="cit48">M. A. El-Moneim, E. H. Elsayed and M. El-Ashry, <span class="italic">J. Pharm. Pharm. Sci.</span>, 2017, <span class="bold">6</span>, 20 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXitFentbbE" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit49">C. Ozen, M. Ceylan-Unlusoy, N. Aliary, M. Ozturk and O. Bozdag-Dundar, <span class="italic">J. Pharm. Sci.</span>, 2017, <span class="bold">20</span>, 415 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXlvFGnt7s%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit50">C. Nitsche, V. N. Schreier, M. A. M. Behnam, K. Kumar, R. Bartenschlager and C. D. Klein, <span class="italic">J. Med. Chem.</span>, 2013, <span class="bold">56</span>, 8389 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm400828u" title="DOI Link to resource 10.1021/jm400828u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrfJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24083834%5Buid%5D" title="PubMed Link to resource 24083834">PubMed</a>.</span></li><li><span id="cit51">B. Orwat, M. Oh, M. Kubicki and I. Kownacki, <span class="italic">Adv. Synth. Catal.</span>, 2018, <span class="bold">360</span>, 3331 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.201800286" title="DOI Link to resource 10.1002/adsc.201800286">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWhsbzP" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit52">S. Reyes and K. Burgess, <span class="italic">J. Org. Chem.</span>, 2006, <span class="bold">71</span>, 2507 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo052576i" title="DOI Link to resource 10.1021/jo052576i">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnurs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16526805%5Buid%5D" title="PubMed Link to resource 16526805">PubMed</a>.</span></li><li><span id="cit53">G. L. French, <span class="italic">J. Antimicrob. Chemother.</span>, 2006, <span class="bold">58</span>, 1107 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jac/dkl393" title="DOI Link to resource 10.1093/jac/dkl393">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ohu7fI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17040922%5Buid%5D" title="PubMed Link to resource 17040922">PubMed</a>.</span></li><li><span id="cit54">T. T. Talele, P. Arora, S. S. Kulkarni, M. R. Patel, S. Singh, M. Chudayeu and N. Kaushik-Basu, <span class="italic">Bioorg. Med. Chem.</span>, 2010, <span class="bold">18</span>, 4630 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bmc.2010.05.030" title="DOI Link to resource 10.1016/j.bmc.2010.05.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXnsVals7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20627595%5Buid%5D" title="PubMed Link to resource 20627595">PubMed</a>.</span></li><li><span id="cit55">P. Ralph, M. A. Moore and K. Nilsson, <span class="italic">J. Exp. Med.</span>, 1976, <span class="bold">143</span>, 1528 <a target="_blank" class="DOILink" href="https://doi.org/10.1084/jem.143.6.1528" title="DOI Link to resource 10.1084/jem.143.6.1528">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE28Xks1Wju7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=1083890%5Buid%5D" title="PubMed Link to resource 1083890">PubMed</a>.</span></li><li><span id="cit56">P. Harris and P. Ralph, <span class="italic">J. Leukocyte Biol.</span>, 1985, <span class="bold">37</span>, 407 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/jlb.37.4.407" title="DOI Link to resource 10.1002/jlb.37.4.407">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaL2M7jtlaitQ%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=3855947%5Buid%5D" title="PubMed Link to resource 3855947">PubMed</a>.</span></li><li><span id="cit57">P. A. Bunn Jr and F. M. Foss, <span class="italic">J. Cell. Biochem. Suppl.</span>, 1996, <span class="bold">63</span>, 123 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Cell.%20Biochem.%20Suppl.%5BJour%5D%20AND%2063%5Bvolume%5D%20AND%20123%5Bpage%5D%20and%201996%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit58">M. S. Anglesio, K. C. Wiegand, N. Melnyk, C. Chow, C. Salamanca, L. M. Prentice and M. K. Shumansky, <span class="italic">PLoS One</span>, 2013, <span class="bold">8</span>, e72162 <a target="_blank" class="DOILink" href="https://doi.org/10.1371/journal.pone.0072162" title="DOI Link to resource 10.1371/journal.pone.0072162">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCrsrrF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24023729%5Buid%5D" title="PubMed Link to resource 24023729">PubMed</a>.</span></li><li><span id="cit59">A. Coates, Y. Hu, R. Bax and C. Page, <span class="italic">Nat. Rev. Drug Discovery</span>, 2002, <span class="bold">1</span>, 895 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrd940" title="DOI Link to resource 10.1038/nrd940">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XotleqtLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12415249%5Buid%5D" title="PubMed Link to resource 12415249">PubMed</a>.</span></li><li><span id="cit60">W. Vollmer, D. Blanot and M. A. de Pedro, <span class="italic">FEMS Microbiol. Rev.</span>, 2008, <span class="bold">32</span>, 149 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1574-6976.2007.00094.x" title="DOI Link to resource 10.1111/j.1574-6976.2007.00094.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Git7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18194336%5Buid%5D" title="PubMed Link to resource 18194336">PubMed</a>.</span></li><li><span id="cit61">V. N. Tra and D. H. Dube, <span class="italic">Chem. Commun.</span>, 2014, <span class="bold">50</span>, 4659 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CC00660G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CC00660G">RSC</a>.</span></li><li><span id="cit62">T. Mendgen, C. Steuer and C. D. Klein, <span class="italic">J. Med. Chem.</span>, 2012, <span class="bold">55</span>, 743 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm201243p" title="DOI Link to resource 10.1021/jm201243p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22077389%5Buid%5D" title="PubMed Link to resource 22077389">PubMed</a>.</span></li><li><span id="cit63">M. I. Konaklieva, <span class="italic">Antibiotics</span>, 2014, <span class="bold">3</span>, 128 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/antibiotics3020128" title="DOI Link to resource 10.3390/antibiotics3020128">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27025739%5Buid%5D" title="PubMed Link to resource 27025739">PubMed</a>.</span></li><li><span id="cit64">A. Zervosen, W. P. Lu, Z. Chen, R. E. White, T. P. Demuth Jr and J. M. Frere, <span class="italic">Antimicrob. Agents Chemother.</span>, 2004, <span class="bold">48</span>, 961 <a target="_blank" class="DOILink" href="https://doi.org/10.1128/AAC.48.3.961-969.2004" title="DOI Link to resource 10.1128/AAC.48.3.961-969.2004">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXitVGhtL0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14982790%5Buid%5D" title="PubMed Link to resource 14982790">PubMed</a>.</span></li><li><span id="cit65">T. Ishida, Y. In, M. Inoue, Y. Ueno, C. Tanaka and N. Hamanaka, <span class="italic">Tetrahedron Lett.</span>, 1989, <span class="bold">30</span>, 959 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0040-4039(00)95290-0" title="DOI Link to resource 10.1016/S0040-4039(00)95290-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3cXhslykt7g%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit66">O. P. Dimitriev, K. P. Grytsenko, O. I. Tolmachev, Y. L. Slominskii, M. A. Kudinova and S. Schrade, Effect of Concentration on Isomerization of Rhodanine Derivatives of Merocyanine Dyes in Polar Solvents, <span class="italic">Adv. Phys. Chem.</span>, 2014, 468910 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Phys.%20Chem.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20468910%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit67">M. Nencki, <span class="italic">J. Prakt. Chem.</span>, 1877, <span class="bold">16</span>, 1 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/prac.18770160101" title="DOI Link to resource 10.1002/prac.18770160101">CrossRef</a>.</span></li><li><span id="cit68">W. Tejchman, A. Skórska-Stania and E. Żesławska, <span class="italic">J. Chem. Crystallogr.</span>, 2016, <span class="bold">46</span>, 181 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10870-016-0644-0" title="DOI Link to resource 10.1007/s10870-016-0644-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kgtrk%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit69">T. B. Johnson and B. H. Nicolet, <span class="italic">J. Am. Chem. Soc.</span>, 1911, <span class="bold">33</span>, 1973 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja02225a014" title="DOI Link to resource 10.1021/ja02225a014">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaC38Xjslyh" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit70">E. J. Tartlon and A. F. McKay, <span class="italic">Can. J. Chem.</span>, 1958, <span class="bold">36</span>, 496 <a target="_blank" class="DOILink" href="https://doi.org/10.1139/v58-071" title="DOI Link to resource 10.1139/v58-071">CrossRef</a>.</span></li><li><span id="cit71">F. E. Hahn, T. Lügger and M. Beinhoff, <span class="italic">Z. Naturforsch., B: J. Chem. Sci.</span>, 2004, <span class="bold">59</span>, 196 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXisV2itb4%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit72">S. Boudiba, A. Růžička, C. Ulbricht, S. Enengl, C. Enengl, J. Gasiorowski, C. Yumusak, V. Pokorná, D. Výprachtický, K. Hingerl, D. R. T. Zahn, F. Tinti, N. Camaioni, S. Bouguessa, A. Gouasmia, V. Cimrová and D. A. M. Egbe, <span class="italic">J. Polym. Sci., Part A: Polym. Chem.</span>, 2017, <span class="bold">55</span>, 129 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/pola.28372" title="DOI Link to resource 10.1002/pola.28372">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xhs1els7zP" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit73">F. de Montigny, G. Argouarch and C. Lapinte, <span class="italic">Synthesis</span>, 2006, <span class="bold">2</span>, 293 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Synthesis%5BJour%5D%20AND%202%5Bvolume%5D%20AND%20293%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit74">G. Zbinden and M. Flury-Roversi, <span class="italic">Arch. Toxicol.</span>, 1981, <span class="bold">47</span>, 77 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/BF00332351" title="DOI Link to resource 10.1007/BF00332351">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL3MXktlKgu78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=7271444%5Buid%5D" title="PubMed Link to resource 7271444">PubMed</a>.</span></li></ol>




<hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available: Synthetic procedures, NMR, IR, LR-MS and ESI-HRMS spectra, MIC and MBC values for selected Gram-positive bacteria, LD<small><sub>50</sub></small> values for human immune cell lines, and PAMPA experiments HPLC chromatograms. See DOI: <a href="http://xlink.rsc.org/?DOI=c9ra08690k" target="_blank" title="Select to resolve DOI: 10.1039/c9ra08690k">10.1039/c9ra08690k</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>